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Summary 
Sequentially acting metabolic enzymes are often positioned in close proximity by the cell using 
three different methods:  attachment to cellular structures, up-concentration in intracellular 
compartments or formation of large enzyme complexes. Positioning sequential enzymes in close 
proximity may accelerate reaction rates and this can prevent the loss of intermediates through 
diffusion, degradation or competing reactions. Most studies on the effect of enzyme proximity 
have been carried out in vitro. These studies have demonstrated that reaction rates may be 
increased by a factor of 1.5-2.5 when two sequential catalytic sites are positioned in the vicinity 
of each other by either fusing the genes encoding the enzymes or by attaching the enzymes to 
some kind of scaffold. Moreover, when experiments were carried out in viscous solutions 
designed to mimic in vivo conditions, the benefits of enzyme proximity were even greater. 
Despite these promising results, very few studies have systematically attempted to use enzyme 
proximity for optimization of metabolic pathways in cell factories.   
    
The aim of this project is to investigate whether two model pathways can be optimized by 
positioning two sequentially acting enzymes in the vicinity of each other. Two different 
strategies for positioning enzymes in close proximity are tested. One method is to construct a 
polypeptide with two catalytic sites by fusing the genes encoding the enzymes. The other is to 
position enzymes on a protein-based platform that self-assembles in vivo. Two industrially 
relevant model systems leading to either sesquiterpene or vanillin glucoside production in yeast 
has been selected for testing the concepts.   
 
In the first part of the project, it is demonstrated that both the sesquiterpene and the vanillin 
glucoside pathway can be optimized by enzyme fusion. With the sesquiterpene system, a two-
fold higher concentration of end product is observed when the two sequential enzymes farnesyl 
diphosphate synthase and patchoulol synthase are fused. Moreover, it is shown to be 
advantageous to use the fusion strategy in combination with other traditional metabolic 
engineering tools, as down-regulation of a competing pathway and enzyme fusion combined 
results in an almost five-fold increase in the concentration of end-product. With the vanillin 
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glucoside pathway, fusion of O-methyl transferase and UDP-glycosyl transferase can effectively 
decrease the accumulation of the toxic intermediate vanillin. The decreased accumulation results 
in a higher growth rate but not in a higher production of end-product. While the effect of enzyme 
fusion is evaluated, the importance of enzyme orientation within the fusion protein is 
investigated. Here, it is shown that the benefits of enzyme fusion are largely dependent on the 
orientation, as no advantages of enzyme fusion are found for some specific configurations of 
fusions proteins. In connection with the testing of sesquiterpene system, the effect of the linker 
type is investigated and for this specific model system, no linker types that significantly affect 
the efficiency of the fusion protein are identified. 
 
The second part of the project focuses on developing and testing a technology that enables 
assembly of sequential enzymes on a protein-based platform in vivo. The concept is in this 
project termed a nano-platform. Here, it is first tested whether the ring-structure forming DNA 
repair protein, Rad52, is suitable as a scaffold for forming the nano-platform core. Secondly the 
developed concept is tested with the two model systems mentioned above. In connection with the 
evaluation of Rad52’s suitability as a scaffold, the mechanism responsible for Rad52’s transport 
to the nucleus is studied in Saccharomyces cerevisiae. Two factors required for nuclear 
localization of Rad52 of S. cerevisiae (ScRad52) are identified. One is a nuclear localization 
signal consisting of three positively charge amino acid residues and a proline residue, the other is 
ScRad52’s ability to self-associate. Based on these findings, an assay for detecting whether 
Rad52 of mouse (MmRad52) self-associates in yeast is developed. Using this assay, it is 
demonstrated that MmRad52 is suitable as a scaffold for assembling of enzymes.  
 
In the last part of the project, the nano-platform concept is tested with the two model pathways 
leading to sesquiterpene and vanillin glucoside production in yeast. For both systems, proximity 
effects could be demonstrated when the enzymes are positioned on the nano-platform, but in 
both cases the system is not advantageous production wise over a system consisting of the free 
counterparts. In the case of the nano-platform tested in this project, the benefits of enzyme 
proximity cannot compensate for the negative effect of fusing enzymes to MmRad52. 
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In summary, it is demonstrated using two simple model systems that the production in cell 
factories can be optimized by enzyme proximity. This illustrates the great potential that the 
engineering of the spatial organization of pathways holds for metabolic engineering.     
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Sammendrag 
Cellen anbringer ofte enzymer, som katalyserer på hinanden følgende trin i en syntesevej, i 
nærheden af hinanden ved at fæstne dem på cellulære strukturer, opkoncentrere dem i 
intracellulære organeller eller samle dem i enzymkomplekser. Ved at anbringe sekventielle 
enzymer tæt på hinanden er det muligt at øge den samlede reaktionshastighed og herved kan det 
forhindres at mellemprodukter mistes ved diffusion, nedbrydning eller til konkurrerende 
reaktioner. Hidtige studier af enzymproksimitet er hovedsalig udført in vitro. Disse studier har 
vist at reaktionshastigheder kan accelereres 1,5-2,5 gange når to katalytiske sites anbringes i 
nærheden af hinanden ved enten at fusionere generne eller ved at fæstne enzymerne til en form 
for platform. Ydermere er det vist at når sådanne forsøg udføres i viskøse opløsninger, som er 
designet til at efterligne in vivo forhold, er fordelene ved enzymproksimitet endnu større.  På 
trods af disse meget lovende resultater, er der imidlertid meget få, der systematisk har forsøgt at 
anvende  enzymproksimitet til optimering af synteseveje i cellefabrikker.  
 
Målet med dette projekt er at undersøge om to modelsynteseveje kan optimeres ved at anbringe 
to sekventielle enzymer i nærheden af hinanden. To forskellige metoder til at anbringe enzymer i 
nærheden af hinanden testes. Den ene metode er at konstruerere et polypeptid med to katalytiske 
sites ved at fusionere af generne, som koder for enzymerne. Den anden metode er at anbringe 
enzymerne på en protein-baseret platform, som samler sig selv in vivo. Som modelsystemer blev 
to industrielt relevante synteseveje valgt. De valgte synteseveje fører til henholdsvis 
sesquiterpen- og vanillinglukosidproduktion i gær.  
 
I første del af projektet vises det at både sesquiterpen- og vanillinglukosidsyntesevejen kan 
optimeres ved enzymfusion. For sesquiterpensystemet vises det at koncentrationen af slutprodukt 
kan øges to gange ved at fusionere de to sekventielle enzymer farnesyldiphosphat syntase og 
patchoulol syntase. Ydermere bliver det vist at fusionsstrategien med fordel kan anvendes i 
kombination med mere traditionelle metabolic engineering strategier, idet det vises at 
nedregulering af en konkurrerende syntesevej og enzymfusion tilsammen øger produktionen 
næsten 5 gange. For vanillinglukosidsyntesevejen vises det at fusion af de to sekventielle 
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enzymer O-methyl transferase og UDP-glykosyl transferase er effektiv til at mindske 
ophobningen af det giftige mellemprodukt vanillin. Den formindskede ophobning af vanillin 
giver anledning til en højere vækstrate, men ikke en højere produktion af slutprodukt. I 
forbindelse med at effekten af enzymfusion bliver evalueret, bliver betydningen af 
enzymrækkefølgen indenfor fusionsproteinet også undersøgt. Konklusionen er at fordelene ved 
enzymfusion afhænger af hvordan proteinerne fusioneres, idet der ikke er nogen fordel ved 
fusion for nogle af de testede enzymorienteringer. For sesquiterpensystemet bliver effekten af 
linkertypen også undersøgt. Her findes det at linkertypen ikke har den store betydning for 
effektiviteteten af fusionsproteinet i dette modelsystem.  
Anden del af projektet fokuserer på at udvikle og teste en teknologi som muliggør samling af 
sekventielle enzymer på en proteinbaseret platform in vivo. Konceptet betegnes i dette projekt en 
nano-platform.  I forbindelse hermed bliver det for det første undersøgt om det 
ringstrukturdannende DNA reparationsprotein Rad52 er egnet til at danne kernen af nano-
platformen og ydermere testes det udviklede koncept med de to ovenfor nævnte modelsystemer. 
I forbindelse med evalueringen af Rad52’s anvendelighed som platformsprotein bliver 
mekanismen, som er anvarlig for transport af Rad52 til kernen i S. cerevisiae, studeret. Her 
findes det at der kræves to ting for at S. cerevisiae Rad52 (ScRad52) sorterer til kernen. Dels 
kræves et kernelokaliserinssignal bestående af tre positivt ladede aminosyrer samt en proline 
rest, dels kræves det at ScRad52 multimeriserer. På baggrund af denne viden udvikles et assay 
som kan benyttes til undersøge om Rad52 fra mus (MmRad52) multimeriserer når dette protein 
udtrykkes i S. cerevisiae. Ved hjælp af dette assay vises det at MmRad52 er egnet til at danne 
platformkernen. 
 
I sidste del af projektet testes det om syntesevejene førende til sesquiterpen- og 
vanillinglukosidproduktion i gær kan optimeres ved at anbringe to udvalgte sekventielle enzymer 
på nano-platformen. For begge systemer påvises der proksimitetseffekter når enzymerne er 
anbragt på nano-platformen, men systemet er ikke konkurrencedygtigt med de frie enzymer rent 
produktionsmæssigt. Dette skyldes formodentlig at fordelene ved enzymproksimitet ikke kan 
opveje den negative effekt, som det har på enzymerne at de blev fusioneret til MmRad52.   
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Sammenfattet bliver det for to simple modelsystemer vist at man ved at anbringe sekventielle 
enzymer i umiddelbar nærhed at hinanden kan opnå fordele. Dette illustrerer det store potentiale 
som  optimering af den rumlige organisering af synteseveje besidder som værkstøj for metabolic 
engineering af cellefabrikker. 
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Nomenclature 
3DSD    3-dehydro shikimate dehydrase  
ACAR   Aromatic carboxylic acid reductase 
C-terminal  carboxy-terminal 
FPPS   Farnesyl diphosphate synthase 
gnDNA  Genomic DNA 
HsRad52  Human Rad52 
MmRad52  Rad52 of mouse 
Nano-platform A structure consisting of a multimeric protein with metabolic enzymes 
linked to it.    
N-terminal  amino-terminal 
OMT   O-methyl transferase encoded by hsOMT 
ORF   Open reading frame 
PAC Protocatechuic acid 
PAL Protocatechuic aldehyde 
Platform subunit A self-associating protein fused to a metabolic enzyme 
PTS   Patchoulol synthase 
PGAL1   The GAL1 promoter of S. cerevisiae 
PGAL10   The GAL10 promoter of S. cerevisiae 
Scaffoldin   A protein based scaffold 
ScRad52  Rad52 of S. cerevisiae 
UGT   UDP glycosyl transferase encoded by UGT72E2 
VALS   Valencene synthase 
VG   Vanillin glucoside
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Introduction  
Nature holds a great treasury of valuable compounds that we use as e.g. medicine, cosmetics and 
food additives. The production of such valuable compounds by conventional chemical methods 
or purification from the biological source is often difficult and expensive (Chang and Keasling, 
2006). Modern recombinant DNA technology allows genes to be transferred from one organism 
to another. In this way, biosynthetic pathways can be transferred to more suitable production host 
organisms such as the yeast S. cerevisiae. The production in such cell factories holds several 
advantages over conventional methods because cell factories are less energy demanding, creates 
less toxic waste in the form of solvents and metal catalysts, uses renewable “building” materials 
and facilitates purification (Chemler et al., 2006).  
 
In nature, clusters of biosynthetic enzymes are often found in the vicinity of each other. By 
positioning enzymes in close proximity the cell can relieve kinetic constraints that result from 
dilution of intermediates and minimise loss of intermediates through degradation and competing 
pathways. When novel pathways are introduced into a cell factory, they depend on the enzymatic 
apparatus of the host as well as on the newly introduced enzymes. In this case no spatial 
organization can be expected to be in place.  Presumably, this contributes to novel pathways 
suffering low productivity and yields as well as the formation of undesired side-products. 
Metabolic engineering aims at solving these problems using a rational, directed approach. In this 
context, modulating the gene expression and activity of enzymes are tools that have been used 
extensively. Another approach that is gaining interest is the engineering of the spatial 
organization of pathways. Although this strategy is used extensively by the cell to efficiently 
regulate metabolism, it has been used to a very limited extent by metabolic engineers. A 
researcher working in the field did however recently state that ignoring the spatial arrangement 
of metabolic pathways when constructing novel pathways “is like laying down the pipes without 
connecting them” (Keasling, 2008), implying that failing to consider the spatial arrangement is 
neglecting some of the most important options for improving cell factories.  
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Objectives 
This project aims at testing whether engineering the spatial organization of pathways can be used 
to optimize cell factories by placing enzymes catalyzing sequential steps in close proximity. Two 
different strategies for positioning enzymes in the vicinity of each other are tested:  
 
1) End to end fusion of the genes encoding the enzymes  
2) Attachment of enzymes to a protein-based scaffold.  
 
As model systems, two industrially relevant pathways were chosen. One that leads to 
sesquiterpene production and one that leads to vanillin glucoside production in yeast. 
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Outline of the thesis 
The thesis is divided into the following chapters: 
 
Chapter 1: Describes the kinetic benefits of enzyme proximity and highlights the types of 
pathways that are most likely to gain from enzyme proximity. Secondly, examples of the cells 
different strategies for spatially arranging pathways are given and lastly the attempts to exploit 
spatial organization for metabolic engineering purposes are reviewed. 
 
Chapter 2: Demonstrates how enzyme fusion can be used to optimize sesquiterpene production 
in S. cerevisiae. The effect of enzyme fusion on the final titer of sesquiterpenes and farnesol is 
examined. Moreover, the importance of enzyme orientation and linker type is investigated. This 
chapter is written in the format of a manuscript and will be submitted to an international journal.   
 
Chapter 3: Illustrates how enzyme fusion may be used to optimize vanillin production in S. 
cerevisiae. The effect of enzyme fusion on intermediate pools, final titers and growth rates are 
examined. 
 
Chapter 4: Explains the concept that was applied for testing the effect of assembling 
sequentially acting metabolic enzymes on a protein-based nano-platform in vivo.  
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Chapter 5: Deals with the identification and verification of a nano-platform core. In this chapter 
the applicability of using two different species of Rad52 as a scaffoldin for assembly of 
metabolic enzymes in vivo is evaluated. A suitable candidate is identified and the concept of 
nano-platform mediated enzyme assembly is verified using YFP and CFP as models enzymes. In 
connection with the evaluation of Rad52’s suitability as a scaffoldin, the localization and 
transport of Rad52 is studied. The chapter is mainly based on the publication: 
Plate, I., Albertsen, L., Lisby, M., Hallwyl, S., Feng, Q., Seong, C., Rothstein, R., Sung, P., and 
Mortensen, U. (2008). Rad52 multimerization is important for its nuclear localization in 
Saccharomyces cerevisiae. DNA Repair, 7(1):57–66.  
 
Chapter 6: Is dedicated to the testing of the concept developed in Chapter 5 with two model 
pathways. The pathways leading to either sesquiterpene or vanillin glucoside production in yeast 
served as model systems. The effect of nano-platform mediated enzyme assembly on growth 
rates, final titers and intermediate pools were examined and some of the problems encountered 
when using this approach were identified. 
 
Chapter 7: Concludes the thesis by summarizing the obtained results. This chapter also proposes 
strategies for further research.   
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Chapter 1: Spatial organization of metabolic enzymes 
The cell often positions sequentially acting enzymes in close proximity. In this way the cell can 
accelerate reactions rates and thereby gain an extra level of metabolic control. In this chapter it 
will be explained how reactions can be accelerated by enzyme proximity and moreover the types 
of pathways that are most likely to gain from this will be highlighted. Furthermore, examples of 
how the cell employs different strategies to spatially arrange pathways will be given and lastly 
the engineering attempts carried out so far are reviewed. 
1.1. Benefits of enzyme proximity  
 One immediate consequence of positioning consecutive enzymes in close proximity is that a 
locally high concentration of substrate builds up in the vicinity of the enzyme catalysing the next 
step in the reaction (See Fig. 1-1A and B). According to the Michaelis-Menten model of enzyme 
kinetics, increases in substrate concentration generally accelerate the reaction rate until the 
enzyme becomes saturated (see Fig. 1-1C).  
 
Figure 1-1. Proximity of sequentially acting enzymes increases the substrate concentration and 
thereby the reaction rate. A) A metabolic pathway where a substrate is converted to a product by 
two sequential enzymes. B) A locally higher concentration of the intermediate (grey cloud) builds 
up around the enzyme catalysing the second step in the pathway (shown in red), if the two 
sequential enzymes are positioned in the vicinity of each other. B) Michaelis-Menten saturation 
curve. The reaction rate increases with the substrate concentration until a saturation point is 
B
A
S I P
C
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reached.  
 
The Michaelis-Menten constant, Km, denotes the substrate concentration at which the reaction 
rate is half of its maximal value (Fig. 1.1C). As physiological substrates concentrations generally 
are in the range of 1/100 to 1 of Km (Stryer, 1995) most reactions can be accelerated by increases 
in substrate concentration. In fact it can be shown that when substrate concentrations are much 
lower than Km, reaction rates increase linearly with both [S] and Kcat/Km, where [S] denotes the 
substrate concentration and Kcat denotes the turnover number of the enzyme, i.e. the number of 
substrate molecules that are turned into product when the enzyme is fully saturated. Several 
natural enzymes have evolved to have high turnover numbers. Under these conditions the 
ultimate limit of Kcat/Km is set by the rate at which the enzyme-substrate complex is formed. This 
rate cannot be faster than the diffusion controlled encounter of enzyme and its substrate (Stryer, 
1995). In this case catalytic gains can only come from decreases in diffusion time. One way that 
diffusion rates can be decreased is by shortening the distance the intermediates have to migrate 
by positioning enzymes catalyzing sequential steps in close proximity. Accordingly, reactions 
that have been optimized through perfection of the enzymes capacity for turning over product 
may be even further accelerated by proximity of sequentially acting enzymes.  
 
1.2. Pathways likely to benefit from enzyme proximity  
When a substrate is converted to a product of interest via an intermediate, an increase in the 
overall reaction rate will generally decrease the transit time of the intermediate and thereby the 
life-time and accumulation of the intermediate can be reduced. These consequences of enzyme 
proximity can be envisioned to be particularly advantageous for several types of pathways 
(Reviewed in Jørgensen et al., 2005). These include pathways with (see also Fig. 1-2): 
Competition for intermediate. For pathways with competition for the intermediate, an 
accelerated conversion of substrate to product can minimize loss of intermediate to competing 
reactions. Competition may arise from non-enzymatic or enzymatic reactions that convert the 
intermediate to undesired by-products.  
Chapter 1: Spatial organization of metabolic enzymes 
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Unstable intermediates. If an intermediate is unstable an accelerated reaction rate can ensure 
that the intermediate is converted to more stable compound before it is lost through degradation. 
Intermediates may also be lost through diffusion. 
Toxic intermediates. Toxic intermediates can inhibit a process by inhibiting cell growth. When 
dealing with toxic intermediates, it can be beneficial for the cell to maintain a locally high 
concentration around the enzymes that convert the intermediate while keeping total cellular 
levels low, as this will minimize the toxic stress imposed on the cell.  
Intermediates that exert inhibitory effects. Intermediates may for example inhibit a pathway 
by directly or indirectly mediating negative feedback on a preceding step. In this case less 
accumulation of intermediates can prevent down-regulation of the pathway.  
 Competition for enzyme. Several cellular enzymes are capable of converting a variety of 
substrates rather than just one. By maintaining a high concentration of the favoured intermediate 
around such a promiscuous enzyme, other substrates or compounds exerting an inhibitory effect 
may be prevented from reaching the active site. In this way the desired reaction may be favoured. 
 
As the metabolism consists of a network of reactions that are widely interconnected, the flux 
through a metabolic pathway is often affected by several of the above mentioned limitations.  
Probably, this also explains why the cell has several strategies for dealing with these types of 
problems.    
Chapter 1: Spatial organization of metabolic enzymes 
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Figure 1-2. Overview of the pathways most likely to benefit from enzyme proximity. A) Pathways 
with competition for intermediate from either enzymatic or non-enzymatic reactions B) Pathways 
with an unstable intermediate that is susceptible to degradation. C) Pathways with a toxic 
intermediate. D) Pathways where the intermediate inhibits the reaction by exhibiting direct or 
indirect product inhibition on a preceding catalytic step or E) Pathways with competition for 
enzyme.   
 
1.3. Organization of metabolic pathways in nature 
Accumulating evidence suggests that the cell employs spatial organization in order to efficiently 
regulate metabolism (Conrado et al., 2008). Instead of being randomly distributed within the cell, 
sequential enzymes often colocalize (Ovadi and Srere, 2000, Ovadi and Saks, 2004). 
Colocalization may for example be achieved by sorting enzymes to the same organelle, by 
docking them on cellular structures or by forming large complexes. Alternatively, proximity of 
catalytic sites may be ensured by encoding them within the same gene. Here, some of the most 
remarkable examples across these themes will be described to illustrate natures intriguing ways 
of optimizing and regulating metabolism using spatial organization (see also Fig. 1-3). 
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 1.3.1. Multifunctional enzymes. 
Multifunctional enzymes that contain one or more catalytic sites are widespread in nature and 
most often catalyze two or more consecutive reactions in a metabolic pathway (Duncan et al., 
1987). Comparative genomics indicate that they at least in some cases have evolved through 
spontaneous fusions of separate genes. For instance, the five central steps in the shikimate 
pathway are catalyzed by one large pentafunctional protein, Arom, in yeast (Fig. 1-3A), whereas 
the same reactions are carried out by five monofunctional enzymes in E. coli (Duncan et al., 
1987). Sequence comparison of the E. coli genes and the yeast gene, showed that there were 
clear sequence similarities between the five functional domains of the yeast protein and the five 
separate E. coli proteins indicating that the yeast protein have evolved through multiple gene 
fusions of common ancestral genes (Duncan et al., 1987). The evolutionary driving force behind 
the creation of multifunctional enzymes is presumably the benefits that can be achieved by 
positioning catalytic sites in close proximity (See section 1.2.). Furthermore multifunctional 
enzymes may resemble structures where substrates can be transferred directly from one catalytic 
site to the next without getting in contact with the cellular matrix – a phenomenon commonly 
referred to as substrate channelling or metabolic channelling.  
 
The synthase catalyzing the last two steps in the biosynthesis of tryptophan is a remarkable 
example of an enzyme displaying such a channelling feature. The bifunctional protein resembles 
a structure where its two catalytic sites are connected by a tunnel with a diameter that exactly 
matches the size of the intermediate indole (Dunn et al., 2008). This tunnel allows indole to be 
transferred from one catalytic site to the next within the molecule without any contact with the 
cellular matrix (Fig. 1-3B). For tryptophan synthase of Salmonella typhirium, this type of 
substrate channelling was shown to increase the reaction rate by 1-2 orders of magnitude (Hyde 
et al., 1988). This result demonstrates the great benefits that can be achieved by transferring 
substrate directly from one catalytic site to the next instead of letting substrates migrate by 
diffusion. 
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1.3.2. Enzyme complexes 
A large number of sequential enzymes from both primary and secondary metabolism have been 
demonstrated to interact and form multifunctional complexes often referred to as metabolons 
(Ovadi and Srere, 1996, Conrado et
complexes may vary in strength and this allows for dynamic pathway regulation (Ovadi & Srere 
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were sufficient (An et al., 2008). Accordingly, the cell can gain an extra level of metabolic 
control by assembling catalytic sites in response to cellular signals.  
 
In another type of enzyme complexes, interactions between sequential enzymes ensure that 
biosynthesis proceeds in an orderly fashion. For example, the synthases involved in the 
production of polyketides form some of the most well-organized enzyme complexes in nature.  
These complexes consist of several functional modules that each performs one cycle of chain 
elongation. The different modules are often encoded by more than one gene, but this does not 
prevent them from cooperating, as the functional modules in this case associate via docking 
domains located at their termini to form large assembly lines where the molecule to be 
synthesized is passed sequentially between functional domains (Weissman, 2006) (Fig. 1-3C). 
Here, specific recognition between acceptor and donor parts of docking domains ensure that 
functional domains assemble in an orderly fashion so random chain elongation is prevented.  
 
Enzyme complexes may also assemble on cellular structures such as the cytoskeleton or internal 
membranes. The pathway leading to synthesis of dhurrin is a good example of a pathway where 
this kind of spatial organization is applied.  Dhurrin is synthesized in seven steps from tyrosine 
by two multifunctional enzymes that dock on the ER membrane and one soluble enzyme that 
glycosylates the final intermediate (Nielsen et al., 2008) (Fig. 1-3D). The last enzyme of the 
pathway is believed to interact with the enzyme catalyzing the preceding step (Nielsen et al., 
2008) and in this way, close proximity of all seven catalytic sites are ensured. As the pathway 
involves a number of labile intermediates, the short distance between the catalytic sites 
supposedly ensures that intermediates are swiftly converted before degradation can occur.  
 
1.3.3. Compartmentation 
In eukaryotic cells, spatial pathway organization may also be achieved by sorting enzymes to a 
membrane enclosed compartment, such as the mitochondria, ER or the microbodies (Ovadi and 
Saks, 2004). Such compartmentation may serve a number of purposes. Intermediates can be up-
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concentrated, a favourable microenvironments that provide optimal conditions for a specific 
reaction can be created or intermediates can be protected from unwanted enzymatic conversions 
or degrading environments. In the terpene pathway of plants, compartmentation is for example 
applied to segregate the pathway branches that lead to synthesis of various types of terpenes, as 
the steps following the common terpene precursor IPP is carried out in various subcellular 
compartments. Monoterpenes are for instance synthesized in the plastids, sesquiterpenes in the 
cytoplasm, sterols and dolichol in ER or the ER membrane and ubiquinone in the mitochondria 
(Bouwmeester, 2006). In this case, the cell can presumably regulate the distribution of the 
common precursors among the different pathway branches by controlling their transport in and 
out of subcellular compartments. 
 
1.4. Engineering the spatial organization of metabolic pathways 
Natures intriguing examples of spatial arrangement of pathways have inspired people to study 
the effect of enzyme proximity using different approaches. Most of this work has been carried 
out in vitro and several of these studies have demonstrated that reaction rates can be increased by 
proximity of sequential enzymes. Moreover, in vitro studies has identified interesting approaches 
for positioning enzymes in close proximity of which some easily can be adapted for  in vivo 
applications. However, despite these promising results, very few studies have systematically 
evaluated the effect of enzyme proximity in vivo. In this section the different approaches for 
positioning enzymes in close proximity will be described, and the results obtained with them will 
be summarized.  
 
1.4.1. In vitro approaches applied for studying enzyme proximity 
The approaches used for studying enzyme proximity in vitro include fusion of enzymes or parts 
of enzymes, interaction via docking domains or assembly on supports via chemical tethering or 
docking domains (See Fig. 1-4). 
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Figure 1-4. Approaches used for studying the effect of enzyme proximy in vitro. A) Covalent linking 
to a scaffold , B) Fusion of enzymes via a linker, C) Assembly on a scaffold protein via docking 
domains (adapted from Mingardon et al., 2007b) , D) Assembly on a self-associating protein via 
docking domains.  
 
1.4.1.1. Enzyme assembly on supports via chemical tethering 
The first attempts to study enzyme proximity focused on assembling enzymes on solid supports 
by covalently linking them to polymer beads such as e.g. sepharose beads (Fig. 1-4A).  When 
two different pairs of sequential enzymes were immobilized in this way, the reaction rate was 
increased 10-140% compared to comparable amounts of free enzymes (See also Table 1) 
(Mosbach and Mattiasson, 1970, Srere et al., 1973). The advantage of being attached to the beads 
was largest when the substrate concentrations were low and no positive effect of attachment to 
the beads was observed when saturating concentrations of substrate were used. In one of these 
studies the cofactor NAD+ is consumed in the first reaction step (Srere et al., 1973). Here, an 
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even greater advantage of enzyme immobilization was observed when a third enzyme that 
regenerates NAD+ was linked to the beads as well. In summary this indicates that the benefits of 
enzyme assembly on supports are achieved through the establishment of a favourable 
microenvironment around the enzymes with a locally higher substrate and/or cofactor 
concentration.  
 
While covalent linking of enzymes to solid supports provides the evidence that pathways can 
benefit from spatial arrangement of sequential enzymes, the usefulness of the approach in vivo is 
limited.  However, more recent experimental work has identified strategies that are more suitable 
for in vivo applications.  
 
Table 1-1:  Effect of enzyme proximity when different methods for positioning catalytic sites in 
close proximity was used. All studies were carried out in vitro.  
Pathway Enzymes (organism) Method Effecta Reference 
     
Pentose phosphate HK (yeast) 
G6PD (yeast) 
Covalent linking 
to scaffold  
1.4-2.4 Mosbach & Mattiasson, 1970 
Citric acid cycle  MD(pig) 
CS (pig)  
Covalent linking 
to scaffold  
1.1-2.3 Srere et al., 1973 
     
Sesquiterpene synthesis  FPPS (Artemisia annua) 
eAS (Nicotiana tabacum) 
Fusion 2.5 Brodelius et al., 2002 
Formaldehyde fixation HPS (Mycobacterium gastri) 
PHI (M. gastri) 
Fusion 2 Orita et al., 2007 
Lactose metabolism β-gal (Escherichia coli) 
galDH (Pseudomonas fluorescens)  
Fusion 2 Carlsson et al., 1996 
Trehalose synthesis TPS (E. coli) 
TPP (E. coli)  
Fusion 1.6 Seo et al., 2000  
     
Cellulose hydrolysis Cel6A (Neocallimastrix patriciarum) 
Cel9G (Clostridium cellulolyticum)  
Assembly on 
scaffold via 
docking domains 
2.5  
 
Mingardon et al. 2007a 
Cellulose hydrolysis Cel6A (N. patriciarum) 
Cel9G (C.  cellulolyticum)  
Cel48F (C. cellulolyticum)  
Assembly on 
scaffold via 
docking domains 
3.1 Mingardon et al. 2007a 
     
aThe effect of enzyme proximity is measured as the fold increase in the overall reaction rate, when enzymes 
engineered to be in the vicinity of each other are compared to equal amounts of their separate counterparts.   
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1.4.1.2. Fusion proteins  
The introduction of modern genetic techniques allowed catalytic sites of sequential enzymes to 
be positioned in close proximity by simply fusing the structural genes and thereby generate a 
polypeptide with more than one catalytic site. Several in vitro studies with purified enzymes 
have shown that the overall reaction rate can be increased up to 2.5 fold by fusion of sequential 
enzymes (See Table 1-1). Moreover, experiments carried out with fusion proteins in 
polyethylene glycol solutions to mimic the crowded environment inside the cell, indicate that the 
positive effects of enzyme fusion may be even greater in vivo (Yilmaz and Bulow, 2002, 
Prachayasittikul et al., 2006, Bülow, 1987).  
 
1.4.1.3. Assembly on scaffolds via docking domains 
In an approach inspired by nature’s way of organizing cellulases on their substrate cellulose, 
enzymes have been assembled on protein-based scaffolds (scaffoldins) via docking domains 
(Fig. 1-4C). Cellulose degrading organisms often express an arsenal of cellulases (Bayer et al., 
2004). In anaerobic microorganisms these enzymes are organized in cellulosomes which consists 
of a scaffoldin possessing a cellulose binding domain and several cohesin domains (Gilbert, 
2007). The cohesin domains are specifically recognized by docking domains that are expressed 
as part of the cellulases. The recognition between cohesion domains and docking domains is 
compatible within species, but incompatible among at least some species of cellulose degrading 
microorganisms (Pages et al., 1997). This can be exploited to position enzymes at specific 
locations on a chimeric scaffoldin displaying cohesin domains from different species (Fig. 1-4C). 
When a fungal and a bacterial endoglucanase were positioned on a chimeric scaffoldin by mixing 
the purified components in vitro a 2.5 fold increase in released sugars was observed (Table 1-1) 
(Mingardon et al., 2007a).  Moreover, accelerated substrate breakdown was observed when an 
additional cellulase displaying endo-processive activity was incorporated in the scaffold . This 
study was not carried out with sequentially acting enzymes but with enzymes that work 
simultaneously on their substrate. Thus, the synergistic effect is not thought to arise from kinetic 
benefits. Instead it is believed to result from the different cellulases ability to enhance each 
other’s access to substrate and thereby enable hydrolysis of additional sites.  The system has 
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been demonstrated to work with various types of cellulases from different organisms (Caspi 
et al., 2008, Fierobe et al., 2001, Fierobe et al., 2002, Fierobe et al., 2005) and can presumably 
also be used for other types of enzymes.  
 
In a further development of the cellulosome inspired concept, cohesin domains were fused to the 
self-associating protein, SP1, capable of forming ring-structures. When SP1 displaying cohesin 
domains was mixed in vitro with a cellulase harbouring a compatible docking domain, large SP1 
complexes exhibiting cellulase activity were observed indicating that the cellulase had 
successfully attached itself to the ring-structure via its docking domain (Fig. 1-4D) (Heyman 
et al., 2007).  
 
Although, the cellulosome inspired strategies seems to be applicable in vivo, no one has reported 
such experiments. In the study with SP1, purification of the protein fused to cohesin domains 
was compromised by the fusion protein’s tendency to form inclusion bodies indicating that there 
are problems to be solved before proper assembly and functioning of enzymes in vivo is a reality. 
But in summary, in vitro studies have identified interesting strategies that remain to have their 
potential demonstrated in vivo.  
 
1.4.2.  In vivo studies of the effect of enzyme proximity 
Most attempts to optimize cell factories by positioning enzymes in close proximity have been 
carried out with fusion proteins. Despite the promising results obtained with fusion enzymes in 
vitro (Table 1-1) and the ease with which the technique can be applied in vivo, the reported use 
of fusion enzymes for pathway optimization has been limited. The few systematic studies that 
have been carried out have generally resulted in decreased titers or yields (Table 1-2). However, 
one noteworthy study did identify a fusion protein displaying superior properties useful in 
metabolic engineering (Meynial Salles et al., 2007). This study was carried out with an E. coli 
strain that had been genetically engineered to couple glycerol production to growth. The strain 
expressed two enzymes from the glycerol pathway of S. cerevisiae from an artificial operon 
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located on a plasmid. When the strain was evolved in a chemostat, a faster growing clone was 
identified and subsequent sequencing of the plasmid revealed that this clone harboured a 
spontaneous deletion between gene 1 and 2 that had resulted in an in frame fusion of the genes. 
Further characterization of the strain expressing the fusion protein showed that for these two 
enzymes, fusion resulted in a five-fold reduced intermediate concentration and a two-fold 
increased production rate. This result demonstrates that enzyme fusion may be a useful tool for 
optimization of pathways in cell factories.  
 
Table 1-2: In vivo studies on the effect of enzyme fusion  
Pathway Enzymes (organism) Host organism Effecta Reference 
     
Sesquiterpene synthesis FPPS (avian) 
PTS (Pogostemon cablin) 
N. tabacum 0.2-0.4 Wu et al., 2006 
Polyhydroxybutyrate production PhaA (R. eutropha) 
PhaB (R. eutropha) 
E. coli 
A. thaliana 
0.2 
0.7 
Kourtz et al., 2005 
Cellulose hydrolysis XhynX (C.thermocellum) 
Cel5Z::Ω (P. chrysanthemi)  
E. coli ~0.5-1 An et al., 2005 
Glycerol production GPD1 (S. cerevisiae) 
GPP2 (S. cerevisiae) 
E. coli 1b Meynial Salles et al., 2007 
     
a Effect is measured as the fold increase in product formed compared to the production from the free enzymes where 
a value of 1 means no difference.  
b
 The productivity is approximately 2 times higher because the growth rate is twice as high for the strain expressing 
the fusion protein. The production per gram biomass is however similar for the fusion and the individual enzymes. 
 
Moreover, fusion proteins have been used with success within a lot of other research fields for 
e.g. studying localization (Huh et al., 2003) and protein interactions (Fields and Song, 1989), for 
enhancing solubility and expression (Chatterjee and Esposito, 2006) and for facilitating protein 
purification (Sheibani, 1999). These studies confirm that proteins often can be fused to other 
proteins or parts of proteins and remain functional in vivo. For the above mentioned applications 
it is however not necessary for the enzymes to retain 100 percent activity, but this becomes 
important when the aim is to use fusion enzymes for metabolic engineering purposes as a 
successful metabolic engineering strategy is dependent on full activity of the enzymes in order to 
benefit from the fusion strategy. Specific activities of fused enzymes have been demonstrated to 
be within the range of 0-100% (Bülow and Mosbach, 1991, Carlsson et al., 1996, Hong et al., 
2006, Orita et al., 2007). From the in vitro studies of fusion proteins, the benefits of enzyme 
fusion are expected to be within the range of 1.5-2.5 fold (Table 1-1). Accordingly, the fusion 
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enzymes probably need to retain approximately 50% of their activity in order to observe any 
benefits and this may explain why attempts carried out to date have been unsuccessful. One 
factor that has been demonstrated to affect the functionality of fusion enzymes is the sequence 
used to link the two proteins to be fused.   
 
1.4.3. Effect of linker length and composition 
All the approaches suitable for studying the effect of enzyme proximity in vivo described above 
require the enzymes to be fused to either another protein or to a docking domain. When fusing 
genes or parts of genes a linker sequence is often inserted in between the ORFs. The function of 
the linker is to serve as spacer between the individual domains to prevent them from interacting 
and interfering with each other’s folding and functionality. Linker length and composition has 
been demonstrated to affect protein stability, folding rates, specific activities and the ability to 
interact with other subunits or proteins (Prescott et al., 1999, Carlsson et al., 1996, George and 
Heringa, 2002). For an artificial fusion enzyme, the specific activity could for example be 
increased 50% by using longer linkers of 9-13 amino acid residues instead of using 3 amino acid 
residues (Carlsson et al., 1996). In this study, one of the fused enzymes was capable of forming 
tetramers and when the long linkers were used, a higher percentage of fusion protein was found 
in large complexes matching the sizes of multimers, indicating that the longer linkers provide the 
freedom in movement required for subunit interaction.  
 
A study conducted to identify tendencies among interdomain linkers in natural multifunctional 
proteins found that natural linkers on average are 10 amino acids long with the majority being 
between 2 and 12 amino acids in length (George and Heringa, 2002). Natural linkers were also 
shown to have a preference for certain amino acids with proline being the most preferred. Short 
proline rich stretches are known to be stiff and proline is the only amino acid with no amide 
bound hydrogen to donate in hydrogen bonding. Thus, the authors speculated that proline is 
favoured because it provides a inert spacer that structurally isolates the linker from the rest of the 
protein (George and Heringa, 2002).  
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When generating artificial fusion enzymes, two main types of linkers have typically been used. 
These linkers are either rigid or flexible in secondary structure depending on the amino acid 
composition. Rigid linkers of variable length may be generated from the helical peptide EAAAK 
repeated 1-5 times (Arai et al., 2001). Flexible linkers are typically rich in glycine and serine and 
may for example be generated from the peptide GGGGS that can repeated if increased length is 
desired. Experimental data indicates that rigid linkers are more efficient in separating domains, 
as the distance between fused proteins was shown to increase with the length of rigid linkers, 
whereas the length of flexible linkers did not affect the distance (Arai et al., 2001).  
As the large variation among natural linkers in both composition and size indicates, the linker 
needed for optimal folding and functioning is probably largely dependent on the individual 
properties of the proteins to be fused. Some may require rigidity, others flexibility. In conclusion, 
an optimal linker should be the best compromise between a linker that provides the separation 
needed for correct folding and the flexibility needed for proper functioning. Lastly, linkers 
should not be susceptible to degradation by proteases. 
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Chapter 2: Enzyme fusion for optimization of sesquiterpene production 
in S. cerevisiae 
 In this chapter and the following chapter, it was tested whether fusion of sequentially acting 
metabolic enzymes can be used for optimization of metabolic pathways. Two different pathways 
that both depended on host as well as heterologous enzymes were selected as model systems. 
One that leads to sesquiterpene production in yeast and one that leads to vanillin glucoside 
production in yeast. The results obtained with the sesquiterpene pathway as a model pathway is 
presented in a manuscript with the title “Fusion of host and heterologous enzymes diverts flux 
towards sesquiterpene production in S. cerevisiae”. The results obtained with the vanillin 
glucoside pathway are presented in Chapter 3. 
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 Abstract 
The ability to transfer metabolic pathways from a normal producer organism to the well-
characterized cell factory Saccharomyces cerevisiae is well documented. However, as many 
secondary metabolites often are produced by several collaborating enzymes in a metabolon, 
metabolite production in yeast may be limited by the inability of the native yeast enzymes to 
collaborate with the heterologously expressed enzymes. To bypass these problems, fusion 
proteins consisting of farnesyl diphophate synthase (FPPS) of yeast origin and patchoulol 
synthase (PTS) of plant origin (Pogostemon cablin) were constructed and expressed in S. 
cerevisiae. Production of the main sesquiterpene produced by PTS, patchoulol, was two-fold 
higher when FPPS and PTS were fused compared to when they were expressed as individual 
enzymes from the same promoters. The higher production of patchoulol from the strain 
expressing the fusion protein FPPS-PTS was not due to a generally higher expression level of the 
fusion protein, as tagging of the free enzymes and the fusion enzyme with fluorescent proteins 
showed that expression levels were similar.  It was also demonstrated that enzyme fusion can be 
used in combination with traditional metabolic engineering strategies to increase the production 
of a desired product. When the fusion strategy was used in combination with ERG9 repression, 
these two modifications combined resulted in an almost five-fold up-regulation reaching a final 
titer of 64mg sesquiterpenes/L media. This work demonstrates that engineering the spatial 
organization of metabolic enzymes around a branch point is of great potential for diverting flux 
towards a desired product. 
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Introduction 
In multistep metabolic pathways, the efficiency of forming the final product may be influenced 
by loss of intermediates through diffusion, degradation or conversion by competitive enzymes 
(For review see Jørgensen et al., 2005). One way to prevent such losses is to increase the overall 
turnover rate of intermediate to product. This may be achieved by coordinating the spatial 
arrangement of enzymes catalyzing consecutive steps in a metabolic pathway.  Close proximity 
of sequentially acting enzymes will speed up intermediate turnover in the pathway, not only by 
reducing the transit time required for the intermediate to reach the enzyme that catalyzes the next 
step in the reaction, but also by ensuring that a high local concentration of intermediate builds up 
in the vicinity of the this enzyme. The latter is important, since the global concentration of a 
metabolic intermediate in most cases is much lower than KM of the enzymatic step that converts 
this intermediate to the next compound (Stryer, 1995). Accordingly, cells often organize 
enzymes acting in the same pathway in close proximity for example by sorting them to the same 
organelle, by docking them on cellular structures such as the ER membrane (Nielsen et al., 
2008), or by allowing them to form large complexes that are often referred to as metabolons 
(Ovadi and Srere, 1996). 
 
One of the goals of metabolic engineering is to optimize metabolic fluxes of pathway 
intermediates towards a desired product. It is therefore and attractive possibility to employ the 
benefits of enzyme proximity to efficiently control the flow of intermediates through a pathway. 
To this end, modern genetic techniques allow catalytic sites to be brought in close proximity in 
several ways. For example, enzymes may be engineered to assemble on supports via docking 
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domains (Fierobe et al., 2001) or be brought to interact via special communication domains 
(Hahn and Stachelhaus, 2006). However, the most simple and most studied approach is to simply 
fuse two genes, which are encoding different enzymatic activities. This allows expression of 
chimerical proteins where two enzymes are fused end-to-end into a single polypeptide. 
Unfortunately, in vivo expression of enzyme fusions has so far resulted in decreased metabolite 
production compared to expression of the separate counterparts (An et al., 2005, Kourtz et al., 
2005, Wu et al., 2006). However, a number of observations suggest that this strategy is still of 
interest for improving the flux though a metabolic pathway. Firstly, several protein fusions 
consisting of sequential enzymes have been characterized in vitro and shown to possess superior 
kinetic properties compared to the individual enzymes. (Brodelius et al., 2002, Carlsson et al., 
1996, Orita et al., 2007, Seo et al., 2000). Secondly, experiments carried out with purified fusion 
proteins in polyethylene glycol solutions to mimic the crowded environment inside the cell, 
indicate that the positive effects of enzyme fusion may be even greater in vivo Yilmaz and 
Bulow, 2002Prachayasittikul et al., 2006Bülow, 1987Lastly, in vivo evolution of an 
Escherichia coli strain where glucose consumption was coupled to glycerol production, selected 
a faster growing strain where two plasmid-borne heterologous genes catalyzing sequential steps 
in the glycerol pathway were spontaneously fused (Meynial Salles et al., 2007), showing that a 
protein fusion may benefit a process. Encouraged by these results we have explored the 
possibilities of using fusion of enzymes in metabolic engineering with Saccharomyces cerevisiae 
as a model. 
 
Isoprenoids constitute an important class of natural compounds that has received considerable 
interest from industry due their potent pharmaceutical, flavor, color and aromatic properties 
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(Maury et al., 2005). As most of the valuable isoprenoids are produced in plants in low amounts, 
great efforts has been put into enabling production in microbial cell factories. Previously, S. 
cerevisiae was demonstrated to be a promising host for isoprenoid production, as it was 
engineered to produce up to 153g/L of the important sesquiterpene amorphadiene, the precursor 
for the antimalarial drug artemisinin (Ro et al., 2006). These high titers were achieved using 
traditional metabolic tools for modulating gene expression, such as over-expression of the 
enzymes involved in precursor synthesis and down-regulation of enzymes that compete for 
precursors. 
  
Here we investigated the possibility of using another approach, namely enzyme fusion, to 
optimize the production of sesquiterpenes in S. cerevisiae. In one test case the gene encoding 
patchoulol synthase (PTS) was fused to the endogenous yeast enzyme farnesyl diphosphate 
synthase (FPPS) and expressed in S. cerevisiae. PTS originates from patchouli (Pogostemon 
cablin) and catalyzes the formation of at least 14 different sesquiterpenes with patchoulol as a 
major product constituting 37% of the produced sesquiterpenes (Deguerry et al., 2006).   The 
substrate for PTS is farnesyl diphosphate (FPP) produced by FPPS. FPP is also the substrate for 
a number of endogenous S. cerevisiae enzymes, including those that are involved in production 
of sterols, dolichols, heme A, quinones, farnesol, and farnesylated mating factors (Grabinska and 
Palamarczyk, 2002)  (Fig. 1), suggesting that a fusion of FPPS and PTS could benefit patchoulol 
production by alleviating some of the competition for FPP. Using this system, we show that 
metabolic engineering may benefit from the construction of an artificial bifunctional enzyme. 
Specifically, our best FPPS-PTS fusion improves patchoulol production approximately two-fold 
compared to free enzymes. Moreover, the effect is additive to improvements obtained by 
Chapter 2: Enzyme fusion for optimization of sesquiterpene production in S. cerevisiae 
  26 
 
  
traditional metabolic engineering, as  ERG9 repression and enzyme fusion combined was 
demonstrated to result in a five-fold increase in sesquiterpene production reaching a final titer of 
64 mg sesquiterpenes/L.  
 
 
Figure 1. The mevalonate pathway in S. cerevisiae. Patchoulol synthase (PTS) has been introduced 
to enable conversion of FPP to 14 different sesquiterpenes including patchoulol. FPP is also the 
substrate for several other enzymes including squalene synthase (ERG9), heme 
A:farnesyltransferase (COX10), hexaprenyl diphosphate synthetase (COQ1), the cis-
prenyltransferases (RER2 and SRT1) and possibly the phosphatases encoded by LPP1 and DPP1. 
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Materials and methods 
Construction of erg20∆ strains 
The genotype and the source of strains used in this study are given in Table 1. To generate a 
heterozygous ERG20/erg20∆ strain auxotrophic for uracil, CEN.PK113-13D and CEN.PK113-
5D were crossed and the resulting diploid was transformed with gene targeting substrates 
designed to knock out ERG20. Gene targeting was performed according to the method described 
by Erdeniz et al., 1997.  HphMX which confers resistance towards Hygromycin B was used as 
a marker. To generate haploid erg20∆ strains expressing PTS and FPPS as separate enzymes or 
fused, the ERG20/erg20∆ strain was transformed with the plasmids pESC-ura (control), pLA001, 
pLA002 and pLA003. The resulting transformants were transferred to sporulation media 
containing galactose and dissection of tetrads was carried out on YPgal using a 
micromanipulator.    
Table 1. Yeast strains used in this study. 
Strain Genotype Source  
CEN.PK113-13D MATalpha MAL2-8c SUC2 ura3-52 Peter Köttera 
CEN.PK113-5D MATa MAL2-8c SUC2 ura3-52 Peter Kötter 
YIP-M0-04 MATa erg9::PMET3-ERG9 MAL2-8c SUC2 ura3-52 Asadollahi et al., 2008 
aInstitut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany. 
Plasmid construction 
A list of all plasmids used in this study is given in Table 2. All DNA sub-cloning steps were 
performed in E. coli DH5 alpha using standard methods described in (Sambrook et al., 2001). 
Correct sequence of the cloned genes was verified by sequencing (MWG-Biotech AG).  
 
A plasmid expressing PTS and FPPS as separate enzymes from the GAL1 and the GAL10 
promoter, respectively, was constructed by insertion of and ERG20 fragment into an EcoRI-ClaI 
Chapter 2: Enzyme fusion for optimization of sesquiterpene production in S. cerevisiae 
  28 
 
  
vector fragment of pIP029. The ERG20 fragment was amplified from genomic DNA obtained 
from CEN.PK113-5D with the primers E3 and E2. To construct a plasmid expressing the fusion 
protein FPPS-PTS, a fragment encoding FPPS-PTS was constructed by separate amplification of 
the genes ERG20 and PatTps177 using the primers E10, E12, P5 and P4. The first round of PCR 
was followed by a second round of PCR in which the two fragments were fused using E10 and 
P4. A fragment containing PTS-FPPS was generated in a similar way except that the primers 
were P6, P7, E8 and E11. The resulting fusion PCR fragments were cut with BamHI and XhoI 
and inserted into a BamHI-XhoI vector fragment of pESC-ura. Flexible, rigid and stable linkers 
were inserted in between ERG20 and PatTps177 by inserting PCR fragments of PatTps177 
generated with one of the following primers as forward primers: P-FL1, P-RL1, P-RL2 or P-SL 
and P4 as reverse primer into a BspEI-XhoI vector fragment of pLA002. To insert CFP as a 
linker, CFP was amplified with G15 and G16 and inserted into a BspEI vector fragment of 
pLA002.    
 
A plasmid expressing ERG20 and PatTps177 tagged N-terminally with YFP and CFP 
respectively was constructed in two steps. Firstly, a fragment encoding YFP-ERG20 was 
amplified with Y2 and E13 and inserted into an EcoRI-SpeI fragment of pESC-ura. Secondly, 
CFP-PatTps177 was amplified using G11 and P4 and inserted into a vector BamHI-XhoI vector 
fragment of the plasmid expressing YFP-ERG20. To N-terminally tag the fusion protein FPPS-
PTS with YFP and CFP, PCR fragments of YFP and CFP were generated with the primers G11 
and G17 and inserted into a BspEI vector fragment of pLA002.  
 
All oligonucleotide sequences are listed in supplementary materials, Table 1. 
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Table 2. Plasmids used in the fusion study. 
Plasmid name  Genotype Source /reference 
pESC-ura 2µ URA3 Stratagene  
pIP029 2µ URA3 PGAL1-PatTps177 Asadollahi et al., 2008 
pLA001 2µ URA3 PGAL1-PatTps177 PGAL10-ERG20 This study 
pLA002 2µ URA3 PGAL1-ERG20-SF-PatTps177 This study 
pLA003 2µ URA3 PGAL1-PatTps177-SF-ERG20 This study 
pLA004 2µ URA3 PGAL1-ERG20-LF-PatTps177 This study 
pLA005 2µ URA3 PGAL1-ERG20-SR-PatTps177 This study 
pLA006 2µ URA3 PGAL1-ERG20-LR-PatTps177 This study 
pLA007 2µ URA3 PGAL1-ERG20-S-PatTps177 This study 
pLA011 2µ URA3 PGAL1-ERG20-CFP-PatTps177 This study 
pLA010 2µ URA3 PGAL1-CFP-PatTps177 PGAL10-YFP-ERG20 This study 
pLA013 2µ URA3 PGAL1-CFP-ERG20-PatTps177 This study 
pLA014 2µ URA3 PGAL1-YFP-ERG20-PatTps177 This study 
 
Media for genetic manipulations 
All media for genetic manipulations of yeast were prepared as described by Sherman et al., 
1986 with minor modifications as the synthetic medium contained twice the amount of leucine 
(60mg/L) and the sporulation media contained galactose instead of glucose. A media allowing 
selection of hygromycin resistant colonies was prepared by adding hygromycin B to YPD to a 
final concentration of 300mg/L media.  
2.2.4. Shake flask experiments  
Shake flask experiments were carried out essentially as described by Asadollahi et al., 2008. 
Briefly described, cultures were grown in 500 ml baffled Erlenmeyer flasks with 100 ml Delft 
mineral media containing 20g/L galactose. In experiments with the strain YIP-M0-04, ERG9 was 
repressed by supplementing the media with 2mM filter sterilized methionine. The pH of the 
mineral media was adjusted to 6.5 by adding NaOH. Shake flasks were incubated in a 30˚C 
shaker running at 150rpm. When cell densities reached OD600 = 0.5-1, an overlay of 10 ml 
dodecane was added to the flasks to collect the volatile sesquiterpenes.  When cultures entered 
stationary phase, the fermentation broth was centrifuged to separate the organic phase from the 
water phase. To determine the sesquiterpene and farnesol content, samples from the organic 
layer was analyzed on a Finnigan Focus GC-MS with a split/splitless injector used in the splitless 
mode.   
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2.2.5. Fluorescence microscopy and quantification 
Fluorescent imaging was carried out essentially as described by Plate et al., 2008. In brief, cells 
were grown O/N at 23 ˚C in SC-Ura media with galactose, spun down and immobilized on a 
glass slide by mixing appropriate amounts of cells with a 1.2% solution of low melting agarose 
(NuSieve 3:1 from FMC). Live cell images were captured with a cooled Evolution QEi 
monochrome digital camera (media Cybernetics Inc.) mounted on a Nikon Eclipse E1000 
camera (Nikon). Images were captured using a Plan-Fluor 100X, 1.3 numerical aperture lense. 
The light source was a mercury arc lamp (Osram, Germany). The fluorophores CFP and YFP 
were visualized with the band pass filters D436/20, 455DCLP, D480/40 and HQ500/20, 
Q515LP, HQ535/30, respectively (Chroma technology).       
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Results 
FPPS-PTS and PTS-FPPS fusions are functional in vivo 
A successful metabolic process based on fusion proteins requires that the chimerical enzyme is 
expressed and soluble, and that its two enzymatic activities are functional. We therefore 
determined the in vivo functionality and solubility of the two possible fusion-configurations, 
FPPS-PTS and PTS-FPPS.  
First, we tested whether FPPS could be fused to PTS and retain activity. As the gene encoding 
FPPS, ERG20, is essential for viability of S. cerevisiae, the functionality of FPPS can be 
evaluated by investigating whether expression of the fusion enzymes can support growth of a 
strain harboring an ERG20 deletion. A heterozygous diploid strain, ERG20/erg20∆, was 
individually transformed with four different versions of a 2µ-based plasmid that contains a 
bidirectional GAL1/GAL10 promoter: one that serves as an “empty” control vector, one that 
expresses PTS and FPPS as free enzymes from the GAL1/GAL10 promoter, and two that express 
fusion enzymes, either FPPS-PTS or PTS-FPPS, from the GAL1 promoter. In the latter two 
cases, the enzymes are fused via a short flexible linker, Gly-Ser-Gly. In agreement with ERG20 
being an essential gene, the strain transformed with empty plasmid produced tetrads containing 
two viable spores (Fig. 2A). In contrast, the three other strains occasionally produced tetrads 
containing four viable spores. Hence, expression of free FPPS, FPPS-PTS or PTS-FPPS, rescue 
the viability of erg20∆ spore-clones. For these strains we also observed tetrads containing less 
than four viable spores. In these cases, the erg20∆ spore(s) likely did not inherit a plasmid. 
Hence, FPPS can be fused N- and C-terminally to PTS and retain activity. 
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Secondly, it was tested whether PTS remains active after fusion to FPPS. As patchoulol is a non-
native yeast compound, we used patchoulol as a reporter metabolite to demonstrate PTS activity. 
Accordingly, haploid ERG20 strains were transformed with the four plasmids described above. 
The four transformed strains were grown in shake flasks using a two-phase fermentation system 
in which dodecane is used as solvent layer to collect volatile compounds such as patchoulol. The 
dodecane phase was analyzed for reaction products on a GC-MS. The peak corresponding to 
patchoulol was identified and confirmed by comparing to the retention-time and mass-spectra of 
a patchoulol standard (Fig. 2B). No production of patchoulol was observed when the strain 
harbored the empty plasmid. In contrast, patchoulol production was observed for strains 
expressing both FPPS-PTS and PTS-FPPS. PTS can therefore be extended N- and C-terminally 
with FPPS and retain PTS activity in vivo. 
 
Figure 2. Functionality FPPS-PTS and PTS-FPPS when they are expressed in S. cerevisiae. A)
Tetrad analysis of a diploid ERG20/erg20∆ strain harbouring an empty plasmid or plasmids 
expressing FPPS and PTS as free enzymes or fused. B) GC spectra for ERG20 strains expressing 
the same plasmids.  The spectre of a patchoulol standard is also shown.  
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Enzyme fusion results in an increased production of patchoulol in S. cerevisiae.  
To investigate whether enzyme fusions may divert the flux more efficiently towards 
sesquiterpene production compared to the corresponding free enzymes, ERG20 strains were 
individually transformed with the four plasmids described above. The resulting strains were 
inoculated into shake flasks in triplicates and grown until stationary phase. At this point, 
patchoulol production was evaluated as described above. The strain transformed with the 
plasmid expressing PTS-FPPS produced patchoulol at the same level as the strain expressing free 
PTS and FPPS (Table 3). More interestingly, the strain transformed with the plasmid expressing 
FPPS-PTS produced patchoulol at a two-fold higher level compared to the strain expressing free 
PTS and FPPS (Table 3), thus, showing that that a fusion protein may benefit a metabolic 
process.  
 
Table 3: Patchoulol (PT) production from ERG20 strains expressing FPPS and PTS as individual 
enzymes or fused from 2µ-based plasmids. 
Proteins expressed  Linker type 
(composition) 
Final PT titer 
[mg/L] 
Final PT yield
[mg/L/OD600] 
- 5.8 ± 1.2  0.209 ± 0.004 
Short flexible        
(GSG) 
9.5 ± 0.6 0.327 ± 0.007  
Short flexible         
(GSG) 
5.7 ± 1.2 0.210 ± 0.056 
Cells were grown in 500ml shake flasks containing 100ml mineral Delft media with 20g/L galactose. Final titers are 
averages of triplicates ± standard deviations.  
FPPS PTS+
FPPS PTS
PTS FPPS
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The observed benefits of enzyme fusion is not due to a higher expression level 
To test whether the increased patchoulol production from the strain expressing FPPS-PTS was 
due to a generally higher expression level of this protein, the expression levels of free and fused 
enzymes was assessed by N-terminally fusing FPPS, PTS or FPPS-PTS to either cyan- or yellow 
fluorescent protein (CFP or YFP, respectively) This was made by extending the relevant ORFs in 
the 2µ-based plasmids described above by the CFP or YFP sequences. The plasmids were 
transformed into an ERG20 strain and inspected by fluorescent microscopy. This analysis 
showed that all protein species produced fluorescent products that were spread evenly in the 
cytoplasm (Fig. 3). This indicates that all protein species are soluble, folded and sorts into the 
same compartment. However, we note that the fluorescent enzyme content varied substantially 
among individual cells. Possibly, this reflects that the population of 2µ plasmids is unevenly 
divided between mother and daughter cells during division. Although, the variation among cells 
makes it hard to assess the expression level, we judged from analysis of several images that the 
expression level of free and fused enzymes was similar. Accordingly, the increased patchoulol 
from the strain expressing the fusion protein is not due to a higher enzyme concentration in these 
cells.  
 
Chapter 2: Enzyme fusion for optimization of sesquiterpene production in S. cerevisiae 
  35 
 
  
 
Figure 3.Cellular localization and expression levels of A) PTS and B) FPPS when they are 
expressed as free enzymes or fused. 
 
Effect of linker length and composition 
 Since specific linkers can presumably favor beneficial conformations of fusion proteins, 
(Carlsson et al., 1996, Lu and Feng, 2008, Robinson and Sauer, 1998, van Leeuwen et al., 1997) 
we proceeded to investigate whether the nature of the linker combining FPPS and PTS can 
influence patchoulol production. To this end, we focused on the configuration FPPS-PTS, and 
examined whether patchoulol production could be further improved by altering the linker 
composition and length. In addition to the short flexible linker, which we already tested, we also 
determined patchoulol production of ERG20 strains expressing FPPS-PTS fused by linker types 
representing: long flexible, short rigid, long rigid, stable, and very long linkers (Table 4). The 
stable linker is a short linker that should be resistant towards degradation by proteases and the 
long linker is in fact the sequence of CFP. The sequences of the remaining linkers can be found 
in Table 4. Strains expressing the five new FPPS-PTS variants were analyzed in triplicates for 
their ability to produce patchoulol. The results of this experiment show that although the FPPS-
DIC CFP
CFP-PTS
CFP-FPPS-PTS
DIC YFP
YFP-FPPS
YFP-FPPS-PTS
 
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PTS fusion has a slight preference for short linkers, no matter whether these linkers are flexible 
or rigid in nature, the linker lengths and compositions do not dramatically influence patchoulol 
production as they all roughly lead to the same patchoulol production. The exception is when 
CFP acts as the linker to connect FPPS and PTS. In this case the amount of patchoulol is lower 
than that obtained by the free enzymes (Table 4). 
 
Table 4: Effect of inserting linkers that varied in length and composition in between FPPS and PTS.   
Proteins expresseda  Linker type 
(composition) 
Effect of linkerb                                              
PT titerlinker / PT titershort flexible linker  
Short flexible        
(GSG) 
1,00  
Long flexible 
(GSGGGGS)  
  0,83 ± 0,02* 
Short rigid 
(GSGEAAAK) 
0,98 ± 0,19  
Long rigid 
(GSGEAAAKEAAAK) 
  0,85 ± 0,03* 
Stable    
(GSGMGSSSN) 
0,82 ± 0,22 
Very long         
(Sequence of CFP) 
 0,33 ± 0,03* 
Cells were grown in 500ml shake flasks containing 100ml Delft media with 20g/L galactose. Final titers are 
averages of triplicates ± standard deviations. 
aProteins were in all cases expressed from 2µ based plasmids from PGAL1. In all cases FPPS was also expressed 
endogenously.  
bThe effect of a linker is given as patchoulol production using this linker relative to production achieved when the 
short flexible linker was used.  
*Patchoulol production using this linker is significantly (p< 0.05) different from when the short flexible linker was 
used.  
FPPS PTS
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Enzyme fusion can be used in combination with traditional metabolic engineering 
strategies to increase the patchoulol production 
Previously, we have used different metabolic engineering strategies to increase production of 
patchoulol (Asadollahi et al., 2008, data not shown). Amongst these, the highest patchoulol 
production was obtained using an ERG9 repressed strain, where the flux towards sterol synthesis 
is reduced (Asadollahi et al., 2008, data not shown). To investigate whether production benefits 
obtained from a fusion enzyme can be additive to those obtained from traditional metabolic 
engineering, we transformed a plasmid expressing FPPS fused to PTS via a short flexible linker 
into a strain in which ERG9 expression is repressed (Asadollahi et al., 2008). As for 
comparisons, this strain was also transformed with a plasmid expressing FPPS and PTS as 
separate enzymes or a plasmid that only expresses PTS.       
 When the fused enzymes were expressed in the ERG9 repressed strain, an almost three-fold and 
five-fold increase in patchoulol production was observed compared to the strain expressing FPPS 
and PTS as free enzymes and the strain that only expresses PTS, respectively (Table 5). The final 
titer of patchoulol was 24 mg/L when ERG9 repression and fusion was combined (Table 5) and 
as patchoulol only constitutes 37% of the total amount of sesquiterpenes produced, this means 
that the final titer of sesquiterpenes reached  64mg/L. Surprisingly, the production of another 
FPP-derived metabolite, farnesol, was also  increased two-fold in the strain expressing FPPS-
PTS.  
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Table 5: Patchoulol (PT) and farnesol (FOH) production in ERG9 repressed strains expressing 
FPPS and PTS as individual enzymes or fused.  
Proteins expresseda  Final PTS titer 
[mg/L] 
Final PT yield 
[mg/L/OD600] 
Final FOH titer 
[mg/L] 
Final FOH yield
[mg/L/OD600] 
4.9 ± 0.7 0.16 ± 0.03 9.7 ± 1.1 0.31 ± 0.05 
8.5 ± 0.1 0.31 ± 0.02 12.2 ± 5.0 0.45 ± 0.21 
23.7 ± 0.9 0.77 ± 0.05 23.8 ± 7.9 0.78 ± 0.27 
Final titers and yields are averages of triplicates ± standard deviations, except that only duplicates were available for 
the strain expressing the fusion protein FPPS-PTS. 
aIn all cases FPPS was also expressed endogenously.  
  
PTS
FPPS PTS+
FPPS PTS
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Discussion: 
In the present study, we demonstrate that enzyme fusion can be successfully used to improve the 
flux through a pathway in the cell factory S. cerevisiae. The process likely benefits from a 
proximity effect of the two active sites to reduce loss of intermediates to other competing 
pathways. Previous attempts to use this concept in vivo have been unsuccessful despite the fact 
that fusion enzymes have proven superior to free enzymes in several in vitro studies Brodelius 
et al., 2002Carlsson et al., 1996Orita et al., 2007Seo et al., 2000.  At least two parameters 
should be considered to obtain successful exploitation of fusion proteins in vivo. Firstly, the 
cellular concentration of correctly folded chimerical protein should be similar to the 
concentrations of the corresponding free enzymes. Secondly, the fusion should not negatively 
affect the activity of the individual catalytic sites. Unfortunately, with our current knowledge, the 
impact of a fusion on these two parameters is not easy to predict. For example, despite that 
fusion of FPPS and PTS can successfully improve patchoulol production, expression of a similar 
fusion of FPPS and valencene synthase, which at the amino acid residue level is approximately 
40% identical to PTS, does not produce additional valencene in S. cerevisiae compared to a 
strain expressing the corresponding two free enzymes (Supplementary materials Table 2) . 
Similarly, when Wu and co-workers expressed a fusion of an FPPS of avian origin and the PTS 
used in this study, they obtained a 5-6 fold lower production in tobacco plants compared to 
production obtained with the free enzymes (Wu et al., 2006). It is therefore necessary to optimize 
fusion of the two enzymes for functionality to benefit from this strategy. For example, the 
configuration of the fusion may play an important role as demonstrated in our study where only 
the fusion of FPPS at the amino terminal part of PTS (FPPS-PTS) improves patchoulol 
production (Table 3). Similarly, since it is well known that correct folding and activity of a 
Chapter 2: Enzyme fusion for optimization of sesquiterpene production in S. cerevisiae 
  40 
 
  
chimerical protein depend on the nature of the linker, it is advisable to create a collection of 
fusion proteins assembled with different linker-types. In our case, the C-terminus of FPPS and 
the N-terminus of PTS appear quite flexible as protein acceptors, since strains expressing FPPS-
PTS connected by different linkers produce patchoulol in similar amounts. The only exception is 
when the two enzymes are linked by CFP. In this case, patchoulol production is reduced to the 
level obtained with free enzymes and we speculate that the distance between the active sites in 
the FPPS-CFP-PTS fusion enzyme is too large to benefit from the proximity effect.  
 
Two facts suggest that the benefit of ERG9 repression is not fully exploited. First, the main effect 
of the mutation is a substantial increase in farnesol production indicating that the increased FPP 
pool is used for farnesol rather than for sesquiterpene production (Asadollahi et al., 2008). 
Secondly, it is known that farnesol mediates product inhibition of an early step in the mevalonate 
pathway by signaling degradation of Hmg2 (Shearer and Hampton, 2005) (see Fig. 1). To 
overcome these problems, we have previously tried to decrease the flux towards farnesol by 
deleting the two genes LPP1 and DPP1, which encode the two phosphatases that are believed to 
be responsible for phosporylation of FPP to FOH (Faulkner et al., 1999). Furthermore, we have 
tried to bypass product inhibition of the HMG-CoA reductase step by over-expression of a 
truncated version of HMG1 that contained the catalytic domain only (Asadollahi, unpublished 
results). Surprisingly, neither of these modifications increased patchoulol production in the 
ERG9 repressed strain. To take advantage of the higher FPP pool in ERG9 repressed strains, we 
therefore decided to investigate the possibility that an FPPS-PTS fusion may redirect the flux 
towards sesquiterpene production; and in the present study we show that this fusion increases 
patchoulol almost three-fold in an ERG9 repressed strain. Surprisingly, farnesol levels were also 
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increased two-fold in this strain. This is somewhat unexpected, as the reaction catalyzed by the 
fusion enzyme is thought to be favored at the expense of other pathway branches starting from 
the FPP node. The fact that farnesol levels are increased is an indication that flux towards FPP is 
generally increased in the fusion strain rendering the possibility that enzyme fusion somehow 
bypasses some of the regulatory circuits of the pathway. One explanation for this could be that 
the fusion of FPPS to PTS blocks FPPS from participating in interactions required for direction 
of FPP into other pathway branches. Although farnesol levels are increased in the strain 
expressing the fusion protein we do however note that the partitioning towards patchoulol is 
increased as the farnesol to patchoulol ratio is decreased approximately 40% when the enzymes 
are fused compared to when they are expressed as free enzymes. This indicates that the benefits 
of enzyme fusion are at least partly due to PTS converting a greater share of the FPP pool. 
 
Based on the above, we conclude that an enzyme-fusion strategy can successfully be used in 
combination with traditional metabolic engineering strategies and contributes to redirecting the 
metabolic flux into a desired pathway. However, we note that farnesol levels are still high in 
ERG9 repressed strains expressing the FPPS-PTS fusion. Accordingly, some FPP may still be 
converted to farnesol by competing enzymes; or alternatively, the FPPS-PTS itself may in fact 
produce farnesol. Moreover, free FPPS, encoded by the endogenous ERG20 locus may also 
contribute to farnesol production. It is therefore likely that further metabolic engineering of the 
ERG9 repressed strains expressing the FPPS-PTS fusion  may additionally improve patchoulol 
production, for example by deleting ERG20 or by relieving product inhibition the mevalonate 
pathway.
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Supplementary Table 1. Oligonucleotides used in this study. 
Primer Sequencea Template 
E2 gtacgtagtgatcgatCTATTTGCTTCTCTTGTAAAC ERG20 
E3 gtatcgtagtgaattcATGGCTTCAGAAAAAGAAATTAGG ERG20 
E8 ATGGCTTCAGAAAAAGAAATTAGGAGAG ERG20 
E10 ccctatgagaggatccATGGCTTCAGAAAAAGAAATTAGGAGAG ERG20
E11 gcggaaaaggctcgagTTATTTACTTCTCTTGTAAACCTTGTTCAAAAACGC      ERG20 
E12  TTTACTTCTCTTGTAAACCTTGTTCAAAAACGC ERG20 
E13 gcggataccactagtctaTTTACTTCTCTTGTAAACCTTGTTCAAAAACGC ERG20
P4 catgatgcgactcgagTTAATATGGAACAGGGTGAA PatTps177
P5 gaacaaggtttacaagagaagtaaagggtccggaATGGAGTTGTATGCCCAAAGTG PatTps177
P6 ccctatgagaggatccATGGAGTTGTATGCCCAAAGTG PatTps177
P7 ctctcctaatttctttttctgaagccattccggagccATATGGAACAGGGTGAAGGTAC PatTps177
P-FL1 gatgatagattccggaggcggtgggtccATGGAGTTGTATGCCCAAAGTG PatTps177 
P-RL1 gatgatagattccggagaagctgcggcaaaaATGGAGTTGTATGCCCAAAGTG PatTps177 
P-RL2 gatgatagattccggagaagctgcggcaaaagaagcagcggctaaaATGGAGTTGTATGCCC
AAAGTG 
PatTps177 
P-SL gatgatagtatccggaatggggagctcttcgaatATGGAGTTGTATGCCCAAAGTG PatTps177 
G2 cgatgagctgacgaattcATGAGTAAAGGAGAAGAACTTTTCACTG YFP and CFP 
G11 ctgtagtggaggatccATGAGTAAAGGAGAAGAACTTTTCACTG YFP and CFP 
G15 gagcgactgtccggaATGAGTAAAGGAGAAGAACTTTTCACTG YFP and CFP 
G16 ctagtgcgtttccggaTTTGTATAGTTCATCCATGCCATGTG YFP and CFP 
G17 ctagtgcaccggatccTTTGTATAGTTCATCCATGCCATG YFP and CFP 
aThe parts of the nucleotide sequences shown in capitals are those that specifically anneal to the template DNA. The 
parts of the oligonucleotides that contain restriction sites and adaptamers are shown in lower-case. 
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Supplementary Table 2. Fusion of FPPS and valencene synthase does not increase the sesquiterpene 
production.  
Proteins expressed from 2µ-based 
plasmidsa
Linker type 
(composition) 
Final valencene titer 
[mg/L] 
- 0.29 ± 0.12 
Short flexible         
(GSG) 
0.25 ± 0.05 
Short flexible        
(GSG) 
0.04 ± 0.02 
Cells were grown in 500ml shake flasks containing 100ml Delft media with 20g/L galactose. Final titers 
are averages of triplicates ± standard deviations. 
aIn all cases FPPS was also expressed endogenously. 
FPPS VALS
FPPS VALS
FPPSVALS
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Chapter 3: Enzyme fusion for optimization of vanillin glucoside 
production in S. cerevisiae. 
3.1. Introduction 
Vanillin is one of the most important aromatic compounds produced by industry with widespread 
applications within industries producing food, beverages, perfumes, cosmetics and 
pharmaceuticals (Barghini et al., 2007, Priefert et al., 2001). The worldwide production exceeds 
12,000 tons per year of which most are chemically synthesized (Yoon et al., 2007). Only 
approximately 0.2% (20-50 tons) of the produced vanillin derives from the botanical source 
(Krings and Berger, 1998). An increased focus on the environmental hazards connected with 
chemical synthesis combined with consumer-driven trends towards producing foods with natural 
flavours rather than synthetic flavours, has enlarged the demand for natural vanillin. The 
production in the natural host is however compromised by limited availability of suitable 
cultivations areas, the plants susceptibility to diseases and the labour intense production method 
(Priefert et al., 2001). One attractive alternative to production in the natural host is to develop 
microbial production platforms for synthesis of natural vanillin. Most of the systems developed 
so far have focused on biotransformation of eugenol or ferulic acid (Priefert et al., 2001). These 
methods suffer from the relatively high price of natural ferulic acid, which is due to its limited 
accessibility from lignin by biological means (Bhathena et al., 2007, Walton et al., 2000). The 
alternative use of synthetic derived substrates removes the label ”natural” from the vanillin 
produced, hereby lowering the price considerably. In an attempt to produce vanillin from the 
much cheaper substrate glucose, de novo vanillin pathways have been engineered into E. coli (Li 
and Frost, 1998) and S. cerevisiae (Hansen et al., 2009). The de novo vanillin pathway 
engineered into yeast is the focus of this study. Here, vanillin is produced in three catalytic steps 
from 3-dehydroshikimatic acid (3DSA) which is produced by the endogenous shikimate pathway 
of yeast (Fig. 3-1). The enzymes catalyzing these three steps were 3-dehydroshikimate dehydrase 
(3DSD) of Podospora pauciseta, aromatic carboxylic acid reductase (ACAR) of Nocardia ssp 
and human O-methyl transferase (OMT).  Moreover, ACAR requires activation by a 
phosphopanteinyl transferase (PPTase) in S. cerevisiae (Hansen et al., 2009). This was achieved 
by expressing the PPTase encoded by the E. coli gene entD. As vanillin is toxic for yeast, even at 
low concentrations (Larsson et al., 2000), a fourth step was inserted to detoxify vanillin by 
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glycosylating it. This was accomplished by expressing a UDP- glycosyl transferase (UGT) of 
Arabidopsis thailana.  
 
Generally, production of vanillin in microbial cell factories is hampered by the cells tendencies 
to rapidly convert vanillin to less toxic compounds such as vanillic acid or vanillyl alcohol 
(Barghini et al., 2007). Metabolic engineering aims at solving such problems using a rational 
approach. One traditional approach involves the identification and knock-out of enzymes 
catalyzing unwanted side-reactions (Chotani et al., 2000). In the case of the vanillin pathway, 
two unwanted reactions were identified. One is the conversion of vanillin to vanillyl alcohol – a 
process that presumably can be carried out by the natural alcohol dehydrogenases of yeast (Fig. 
3-1). To inhibit this process, several different alcohol dehydrogenase mutants were tested for 
their ability to reduce the conversion of vanillin to vanillyl alcohol (Hansen et al., 2009). The 
screen showed that deletion of the alcohol dehydrogenase encoded by ADH6 could reduce 
formation of vanillyl alcohol without impairing growth (Hansen et al., 2009). Another unwanted 
reaction is catalyzed by the β-glucosidase encoded by BGL1. This enzyme rapidly reverses the 
reaction catalyzed by UGT and converts vanillin glucoside (VG) back to vanillin. To avoid these 
unwanted reactions, a strain carrying deletions of ADH6 and BGL1 was used in this study.  
 
Another approach for pathway optimization that has been gaining increasing interest recently is 
the engineering of the spatial organization. In chapter 2, it was shown that flux could be diverted 
towards patchoulol production by positioning the catalytic sites of two consecutive enzymes in 
close proximity by enzyme fusion. Here, it is tested whether this approach also can be applied to 
optimize VG production in S. cerevisiae. To this end, the enzymes catalyzing last two steps in 
the pathway, namely OMT and UGT were positioned in close proximity by enzyme fusion. 
There are several reasons why the vanillin pathway is particularly likely to benefit from 
proximity of these two enzymes. First, vanillin is known to be toxic and has been reported to 
inhibit growth of yeast in relatively low concentrations (Larsson et al., 2000). By keeping OMT 
and UGT in close proximity, reaction rates can be increased and this may prevent vanillin 
accumulation and thereby minimize growth inhibition. Secondly, UGT is believed to work on a 
number of substrates in yeast, including the early intermediates of the vanillin pathway. 
Accordingly, there is competition for enzyme. Moreover, if early intermediates such as PAC and 
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PAL are glycosylated, it is unsure whether they can serve as substrates for ACAR and OMT. By 
positioning OMT and UGT in close proximity, it may be possible to get UGT to preferentially 
glycosylate vanillin. In this way, the glycosylation of vanillin may be favoured and the 
conversion of early pathway intermediates into useless compounds may be prevented. Thirdly, 
vanillin is believed to be the substrate for several other enzymes that convert it to less to toxic 
compounds. Moreover, it readily diffuses out of the cell. Accordingly, there is competition for 
substrate. But by positioning enzymes in close proximity loss through diffusion and competing 
reactions may be minimized (see also section 1.2.).  
 
 
Figure 3-1. De novo pathway leading to vanillin glucoside production in yeast. Five enzymes were 
introduced to allow vanillin glucoside production in yeast from 3-dehydroshikimic acid. The 
enzymes catalyzing the two first steps, 3-dehydro shikimate dehydrase (3DSD) and aromatic 
carboxylic acid reductase (ACAR) were expressed as separate enzymes from the genome. ACAR 
requires activation by a phosphopanteinyl transferase (PPTase). This was achieved by expressing 
the PPTase encoded by the E. coli gene EntD from a CEN-based plasmid. The enzymes catalyzing 
the last two steps in the pathway, O-methyl transferase (OMT) and the UDP-glycosyl transferase 
(UGT) were expressed as free enzymes or fused from a 2µ-based plasmid.  
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3.2. Materials and Methods 
3.2.1. Strains and media 
All media for genetic manipulations of yeast were prepared as described by Sherman (Sherman 
et al., 1986) with minor modifications as the synthetic medium contained twice the amount of 
leucine (60 mg/L).  
 
For shake flasks experiments Delft mineral media composed of 7.5 g/L (NH4)2SO4, 14.4 g/L 
KH2PO4, 0.5 g/L MgSO4 *7H2O, 2 mL/L trace metal solution, 1 mL/L vitamin solution and 50 
µL/L synperonic antifoam was used. In all cases Delft media was supplied with galactose 
(20g/L) and methionine (21g/L). The pH of mineral medium was adjusted to 6.50 by adding 2 M 
NaOH. Vitamin and amino acids were sterile filtered and added after autoclavation. 
 
To construct a strain producing PAL, VAN265 was transformed with pJH674 which had been 
linearized in the TPI1 promoter with SphI. Transformants were plated on YPD based media 
containing aureobasidin A (Takara Bio Inc.) and hygromycin B (Sigma Aldrich) to a final 
concentration of 0.5 mg/L and 300 mg/L media, respectively.  
 
Table 3-1. Strains used in this study 
Strain 
name 
Genotype Source 
VAN265 Mata, adh6::LEU2, bgl1::KanMX4, his3∆1, leu2∆0, 
met15∆0, ura3∆0, PTPI1::3DSD [AurC] 
Hansen et al., 2009 
VAN265JH Mata, adh6::LEU2, bgl1::KanMX4, his3∆1, leu2∆0, 
met15∆, ura3∆0, PTPI1::3DSD- [AurC]::ACAR [HphMX] 
This study 
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3.2.2. Plasmid construction 
A list of all plasmids used in this study is given in Table 3-2. All DNA sub-cloning steps were 
performed in E. coli DH5 alpha using standard methods described in (Sambrook et al., 2001).  
To construct a plasmid expressing OMT and UGT as free enzymes from PGAL1 and PGAL10 
respectively, OMT was amplified by PCR with the primers O1 and O3. The resulting PCR 
fragment was cut with BamHI and XhoI and inserted into a BamHI-XhoI vector fragment of 
pESC-his. Subsequently, a PCR fragment of UGT was amplified with the primers U1 and U3, 
and inserted into a ClaI-PacI of the OMT containing vector. To generate a DNA fragment 
encoding OMT-UGT, the two genes were separately amplified using the primers O1, O4, U8 and 
U7 and subsequently they were fused in a second round of PCR with the primers O1 and U7. 
The resulting OMT-UGT fragment was digested with BamHI and XhoI and inserted into a 
BamHI-XhoI vector fragment of pESC-his. The plasmid expressing UGT-OMT was generated in 
an equivalent way except the primers were U5, U6, O5 and O6.  
The sequence of all oligonucleotides used for plasmid construction is given in Table 3-3.  
 
Table 3-2. Plasmids used in this study 
Strain name Genotypea Source 
PJH674 PTPI1ACAR, hphMX Hansen et al., 2009 
pJH589 CEN, URA3, EntD  Hansen et al., 2009 
pJH543 PTPI1hsOMT, NatMX Hansen et al., 2009 
pJH665 CEN, URA3, PTPI1UGT72E2 Hansen et al., 2009 
pESC-his HIS3 Stratagene 
pESC-his-OMT+UGT 2µ, HIS3, PGAL1hsOMT, PGAL10UGT72E2 This study 
pESC-his-OMT-UGT 2µ, HIS3, PGAL1hsOMT-UGT72E2 This study 
pESC-his-UGT-OMT 2µ, HIS3, PGAL1UGT72E2-hsOMT This study 
aThe genes encoding ACAR and HsOMT had been codon optimized for yeast. 
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3.3.3. Shake flask experiments 
Shake flasks experiments were carried out in 500 ml baffled Erlenmeyer flasks with 100 ml Delft 
mineral media containing 20g/L galactose and 21g/L methionine. Shake flasks were inoculated 
with precultures to an initial OD600 of 0.05. Samples for OD600 measurement and HPLC analysis 
were taken at time points 0, 13.5, 19.5, 28, 35, 62.5 hours after inoculation. For HPLC analysis 
an Agilent ChemStation LC30 was used and concentrations of metabolic products were 
determined by comparing them to standard curves.  
 
Table 3-3. Oligonucleotides used in this study.  
Primer name  Sequencea Template 
O1 agcatgacttaggatccATGGGTGACACTAAGGAGC hsOMT 
O3 tctatcatggctcgagTTATGGACCAGCTTCAGAACC hsOMT 
O4 TGGACCAGCTTCAGAACCTG hsOMT 
O5 ggacttgtcacgtggtgccgggtccggaATGGGTGACACTAAGGAGC hsOMT 
O6 ctaagataggccgcggTTATGGACCAGCTTCAGAACC hsOMT 
U1 ttcaacatccatcgatcATGCATATCACAAAACCACACG UGT72E2 
U3 tgatagatccttaattaaCTAGGCACCACGTGACAAG UGT72E2 
U5 ccagtagttgggatccATGCATATCACAAAACCACACG UGT72E2 
U6 GGCACCACGTGACAAGTCC UGT72E2 
U7 agtactaggcccgcggCTAGGCACCACGTGACAAG UGT72E2 
U8 caggttctgaagctggtccagggtccggaATGCATATCACAAAACCACACG UGT72E2 
aThe parts of the nucleotide sequences shown in capitals are those that specifically anneal to the template DNA. The 
parts of the oligonucleotides that contain restriction sites and adaptamers are shown in lower-case.  
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3.3. Results 
3.3.1. Enzyme fusion results in decreased intermediate accumulation and increased growth 
rates 
To investigate whether the de novo vanillin pathway could be optimized by fusion of the 
enzymes catalyzing the last two steps in the pathway, namely OMT and UGT, a strain producing 
the substrate for OMT, protocatechuic aldehyde (PAL), was constructed. This was done by 
integrating ACAR into the genome of a strain that already expressed 3DSD from the genome. 
The strain also harboured deletions of BGL1 and ADH6 to avoid unwanted side-reactions.  To 
activate ACAR the strain was transformed with a CEN-based plasmid expressing the PPTase 
encoded by EntD. In a preliminary experiment both ACAR and 3 DSD were shown to be active 
in this strain, as PAL accumulated in the media of an O/N culture (data not shown). It was 
however noted that large amounts of the substrate for ACAR, protocatechuic acid (PAC), also 
accumulated in the media indicating that ACAR possibly is not fully activated by the PPTase 
from E. coli.  
 
To evaluate the effect of enzyme fusion, the PAL producing strain was transformed with 2µ-
based plasmids expressing OMT and UGT as free enzymes or fused in the two possible 
configurations, OMT-UGT or UGT-OMT. The strains were grown in shake flasks until 
stationary phase while growth and the formation of metabolic products was followed by 
measuring OD600 and taking samples for HPLC analysis at time points 0, 13.5, 19.5, 28, 35, 62.5 
hours after inoculation.  
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Figure 3-1. Summary of shake flask results for strains expressing OMT and UGT as free enzymes 
(OMT+UGT) or fused in the two possible configurations (OMT
Concentrations of A) vanillin glucoside (VG) and B) vanillin (VAN) in the media at time points 0, 28, 
35 and 62.5 hours after inoculation. C) Growth rates of the same three strains given as averages of 
triples ± standard deviations. 
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3.4. Discussion 
Here, it is shown that accumulation of the toxic intermediate vanillin can be significantly 
decreased by fusion of the two enzymes OMT and UGT, when they are fused in the 
configuration UGT-OMT.  This is likely due to fusion induced proximity effects, as proximity of 
catalytic sites can reduce intermediate transit times and thereby minimised accumulation of 
intermediates. Moreover, the strain expressing UGT-OMT seems to benefit from the reduced 
accumulation of vanillin as the strain displays a 14% higher growth rate. Presumably, the higher 
growth rate also explains why VG production occurs faster in this strain. The final titer of VG is 
however not increased in the strain expressing UGT-OMT. Possibly, greater benefits of fusion 
could be observed under less optimized conditions. In this study, a strain that has already been 
partly optimized for VG production by deletion of ADH6 which catalyzes a competing reaction 
was used.  Moreover, although vanillin accumulation was observed in this study, concentrations 
are very low compared the minimal inhibitory concentrations reported by others (Klinke et al., 
2004) rendering the possibility that greater benefits of enzyme fusion could be observed under 
conditions where accumulation of vanillin is more pronounced.  
 
When vanillin is present in the fermentation media it has been demonstrated to inhibit growth in 
concentrations as low as 1mM (Larsson et al., 2000). In this study vanillin concentrations in the 
media were at all times less than 4 mg/L (Fig 3-1B) which is equal to less than 0.03mM. 
Accordingly, the concentrations observed in this study are much lower, than the concentrations 
that have previously been demonstrated to inhibit growth. We do however measure the vanillin 
concentration in the media and can therefore not rule out that concentrations inside cells were 
larger.   
 
In all three strains flux towards vanillin seems to be limited by ACARs low turnover of PAC to 
PAL, as a substantial accumulation of PAC was observed in all strains (data not shown). 
Possibly, this is because ACAR is not optimally activated by the PPTase of E. coli which was 
used in this study. In a recent study, the activity of ACAR was increased 20-fold in E. coli when 
it was co-expressed with the PPTase that derives from a Nocardia species (Venkitasubramanian 
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et al., 2007). This suggests that the PPTase of Nocardia is more efficient in activating ACAR 
than the E.coli PPTases. Accordingly, flux towards vanillin can possibly be increased by 
expressing another PPTase than the one used in this study. Once this bottleneck has been 
removed, greater benefits of enzyme fusion could perhaps be demonstrated, because vanillin 
accumulation under these circumstances would be expected to be more pronounced. 
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Chapter 4: Introduction to the nano-platform concept 
In Chapter 2 and 3, it was demonstrated that cell factory engineering can benefit from 
positioning catalytic sites in close proximity by enzyme fusion. This inspired the development of 
another more flexible approach for exploiting proximity effects in vivo. The second strategy was 
to use a self-associating protein to guide the assembly of metabolic enzymes. If metabolic 
enzymes are fused to a scaffold protein (scaffoldin) that is able to self-associate and form a 
multimeric structure such as e.g. a ring-structure, the enzymes will automatically be positioned in 
close proximity once the scaffoldin self-associates in vivo (Fig. 4-1). Here, the term nano-
platform is used to describe a structure consisting of a multimeric scaffoldin with metabolic 
enzymes linked to each of its subunits. Each subunit of the nano-platform can be expressed 
separately and subsequently the nano-platform is assembled post-translationally. For simplicity, 
the concept is shown here with three metabolic enzymes but several enzymes could be added to 
the nano-platform. The second part of this project aimed at developing the technology for 
constructing such a self-assembling nano-platform.  
 
 
Figure 4-1. Nano-platform concept. When fusion proteins consisting of a self-associating protein 
linked to three different metabolic enzymes are expressed, the self-associating protein will assemble 
and form a nano-platform with three metabolic enzymes attached to it.  
 
Assembled nano-platformConstructs
Transcription & 
translation
Expressed fusion proteins
Self-association 
of the scaffoldin
TE1scaffoldin
TE2scaffoldin
TE3scaffoldin
Metabolic pathway: A   →   B   → C   → D
E1 E2 E3
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4.1. Requirements to the scaffoldin   
In order to serve as an ideal custom nano-platform core, the scaffoldin must possess several 
properties. Most importantly, the scaffoldin should be able to self-associate and form a stable 
multimeric structure that does not affect metabolism negatively. Moreover, it should be possible 
to tag the scaffoldin both C- and N-terminally without interfering with its ability to self-
associate, as this allows the metabolic enzymes to be fused to the scaffoldin via their preferred 
terminal. Furthermore, the scaffoldin’s localization and mobility is important since metabolic 
processes takes place in various organelles. To provide the most universal application of the 
concept, the scaffoldin should preferably have the ability to sort to any organelle of interest if 
tagged with a proper signal peptide.  Lastly, the scaffoldin’s ability to be highly expressed and 
properly folded are important parameters. When two enzymes are fused, misfolding can be a 
problem particularly if the resulting fusion proteins are large in size. For this reason it is of 
interest to minimize the size of the scaffoldin to ensure high functionality. 
 
4.2. Advantages of a self-assembling nano-platform 
There are several advantages of assembling metabolic enzymes on a nano-platform instead of 
directly fusing them: 
1) Several enzymes can be attached to the nano-platform without having to express 
large proteins. The number of enzymes that can be attached to the nano-platform is 
theoretically only limited by the number of subunits in multimeric structure formed by 
the scaffoldin. As several proteins are known to form multimers with more than 12 
subunits (Jones and Thornton, 1996), nano-platforms with more than 12 enzymes 
attached to it could theoretically be constructed. If on the other hand, 12 catalytic sites 
were to be positioned in close proximity by direct fusion of the genes, the resulting fusion 
protein would most likely display severe folding problems.  
2) Ratios of the expressed metabolic enzymes can be tuned. When enzymes are fused to 
each other the ratio will always be 1 to 1, but when enzymes are fused to a scaffoldin it is 
possible to change the ratio between the enzymes by expressing the various nano-
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platform subunits from different promoters.  This may for example be an advantage if 
one of the enzymes has a much lower activity than the other. 
3) Folding problems can be minimized. Misfolding is a general problem when working 
with fusion proteins. In the case where enzymes are fused to a scaffoldin instead of each 
other, a scaffoldin that folds well may be selected as the fusion partner and this may 
reduce misfolding.  
4) Enzymes can be fused at their preferred terminal. Some proteins are only functional 
when they are tagged at a specific terminal (Orita et al., 2007, Hong et al., 2006). If 
wanting to coordinate two enzymes that are functional only when tagged via their N-
terminal, it would be impossible to construct a functional fusion protein as one protein 
inevitably has to be fused via the C-terminal and the other via the N-terminal. In this case 
fusion to the scaffoldin, that allows the enzymes to be tagged at their preferred terminal, 
would be the only solution. 
4.3. Rad52 as a scaffoldin candidate 
Initially, Rad52 was identified as a good scaffoldin candidate because this protein possesses the 
following properties:  
1) Rad52 forms ring-structures with 7-11 subunits in the ring depending on whether the full-
length protein or a C-terminal truncation is expressed (Shinohara et al., 1998, Ranatunga 
et al., 2001b, Stasiak et al., 2000) 
2) The crystal structure has been solved for a C-terminal truncation of human Rad52 
(HsRad52-∆212) (Kagawa et al., 2002, Singleton et al., 2002). The fact that the crystal 
structure is known may facilitate further protein engineering of the scaffoldin.  
3) Tagging with other proteins does not seem to impair the functionality of Rad52 of S. 
cerevisiae (ScRad52), as ScRad52-YFP is biologically functional and can repair DNA 
almost as efficiently as the wild type protein (Lisby et al., 2001). 
4) The functional domains involved in self-association, DNA-binding and association to 
other proteins have been mapped (Cortes-Ledesma et al., 2004, Hays et al., 1998, Krejci 
et al., 2002, Mortensen et al., 1996, Mortensen et al., 2002, Park et al., 1996, Ranatunga 
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et al., 2001b, Shen et al., 1996). This may greatly facilitate the construction of inert 
mutants.    
5) The rings-structure has been demonstrated to be remarkably stable as it is extremely 
resistant to heat (Ranatunga et al. 2001) 
 
In summary, Rad52 fulfils several of the requirements to an ideal scaffoldin candidate. Little is 
however known about Rad52’s mobility. GFP-tagging has demonstrated that it localizes to the 
nucleus, but the mechanism of transport is unknown. As mentioned in the requirements to the 
ideal scaffoldin, the scaffoldin should preferably be mobile. Initially, a cytosolic localization 
would however be preferred, as several of the processes of interest to cell factory engineering 
takes place in the cytosol and as the cytosol generally serves as a starting point for sorting of 
proteins to other organelles. For this reason it was of interest to learn more about how Rad52 is 
transported to the nucleus and if possible, identify a nuclear transport mutant that resides in the 
cytosol. In the following chapter the results leading to the identification of a suitable scaffoldin is 
presented and in the subsequent chapter the concept is tested with two model pathways. 
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Chapter 5: Evaluation of Rad52’s applicability as a scaffoldin for enzyme 
assembly in vivo. 
 
This chapter presents the results of the experiments that were carried out to identify a scaffoldin 
that allows the assembly of metabolic enzymes on a nano-platform in vivo. The study was carried 
out in S. cerevisiae and the native yeast protein ScRad52 served as a starting point for the 
identification of a suitable scaffoldin. Except for its localization, ScRad52 fulfils the 
requirements to an ideal scaffoldin. In an effort to learn more about ScRad52’s mobility, the 
mechanism of nuclear transport was studied.  
 
The first part of the results in this chapter describes the biological mechanism underlying nuclear 
transport of ScRad52. This part has been published in separate publication:  
Plate, I., Albertsen, L., Lisby, M., Hallwyl, S., Feng, Q., Seong, C., Rothstein, R., Sung, P., and 
Mortensen, U. (2008). Rad52 multimerization is important for its nuclear localization in 
Saccharomyces cerevisiae. DNA Repair, 7(1):57–66.  
 
In the second part of this chapter, the work published in Plate et al., 2008 is interpreted with 
respect to the applicability of ScRad52 as a scaffoldin and it is concluded that ScRad52 is not a 
good scaffoldin candidate. Lastly, Rad52 of mouse (MmRad52) is evaluated as a scaffoldin 
candidate and found to be suitable backbone for enzyme assembly in S. cerevisiae.      
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a b s t r a c t
Rad52 is essential for all homologous recombination and DNA double strand break repair
events in Saccharomyces cerevisiae. This protein is multifunctional and contains several
domains that allow it to interact with DNA as well as with different repair proteins. How-
ever, it has been unclear how Rad52 enters the nucleus. In the present study, we have used
a combination of mutagenesis and sequence analysis to show that Rad52 from S. cerevisiae
contains a single functional pat7 type NLS essential for its nuclear localization. The region
containing the NLS seems only to be involved in nuclear transport as it plays no role in repair
of MMS-induced DNA damage. The NLS in Rad52 is weak, as monomeric protein species that
harbor this NLS are mainly located in the cytosol. In contrast, multimeric protein complexes
wherein each subunit contains a single NLSRad52 sort efficiently to the nucleus. Based on the
results we propose a model where the additive effect of multiple NLSRad52 sequences in a
Rad52 ring-structure ensures efficient nuclear localization of Rad52.
© 2007 Elsevier B.V. All rights reserved.
1. Introduction
The integrity of the genome is constantly challenged by
DNA damage induced by reactive metabolic intermediates
and environmental agents. Among the different types of
DNA lesions that can occur, DNA double strand breaks are
particularly dangerous, as they may cause cell death or pro-
voke genomic rearrangements. In Saccharomyces cerevisiae,
DNA double strand breaks are mainly repaired by pathways
that involve homologous recombination (HR). HR depends
on the genes of the RAD52 epistasis group, RAD50, RAD51,
RAD52, RAD54, RAD55, RAD57, RAD59, RDH54, RFA1, MRE11
and XRS2 [1]. Among these, mutations in RAD52 show the
most severe phenotype, reflecting the involvement of this
gene in multiple HR pathways. The importance of Rad52
∗ Corresponding author. Tel.: +45 4525 2701; fax: +45 4588 4148.
E-mail address: um@biocentrum.dtu.dk (U.H. Mortensen).
is stressed by the fact that it is conserved from yeast to
human.
Several biochemical properties of Rad52 are germane for its
HR role, including DNA binding and an ability to interact with
the Rad51 recombinase, Rad59 protein, and the single-strand
DNA binding protein RPA. These attributes enable Rad52 to
promote the annealing of RPA-coated ssDNA and to function
with Rad51 in the displacement of RPA from ssDNA [2–9]. The
highly conserved N-terminus of Rad52 contains domains that
allow it to self-associate and form ring-structures, to bind
Rad59, to bind DNA and to facilitate DNA annealing (Fig. 1)
[7,2,8–11]. The middle- and C-terminal regions of yeast and
human Rad52 proteins have been shown to contain the RPA
and Rad51 interaction domains, respectively, but are other-
wise not well conserved in primary sequence [12,13,2,14,15]
1568-7864/$ – see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.dnarep.2007.07.016
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Fig. 1 – Functional map of Saccharomyces cerevisiae Rad52 and an overview of the cellular localization of all Rad52 mutants.
A schematic representation of Rad52 from S. cerevisiae is presented in the top. The hatched region covering aa residues 1–33
is not expressed. The dark region spanning aa residues 34–198 corresponds to the region of Rad52 that is highly
evolutionary conserved. The regions in Rad52 that are involved in protein–protein interactions and in binding to DNA are
indicated. A diagram showing all individual Rad52 deletion and mutated species relative to wild-type Rad52 is presented
below. All Rad52 species are C-terminally extended by YFP (not shown in the figure). Rad52-YFP (Wt), Rad52-327-YFP
(327), Rad52-267-YFP (267), Rad52-237-YFP (237), Rad52-223-YFP (223), Rad52-207-YFP (207), Rad52MC-YFP
(MC), Rad52C-YFP (C), Rad52-207-237-YFP (207-237), Rad52-R148A-YFP (R148A), Rad52-K150A-YFP (K150A),
Rad52-KRR233-235AAA-YFP (KRR233-235AAA) and Rad52-R234A-YFP (R234A). The position of single aa residue
substitutions are indicated with stars and the pat7 NLS region is indicated below the figure. To the right, the cellular
localization of individual Rad52 species and whether it is expressed from the genomic RAD52 locus or from a vector is
shown. Nuclear and cytosolic localization of a given Rad52 species is indicated by (+) and (−), respectively.
(Krejci et al., submitted). Notably, it has remained unclear how
Rad52 is transported into the nucleus.
Most nuclear proteins larger than 40–60 kDa require active
transport to enter the nucleus [16]. This transport is facilitated
by nuclear transport receptors, importins, which recognize
nuclear localization signals, NLSs, which are typically com-
posed by clusters of basic amino acid (aa) residues [16]. The
complex of a cargo protein and a nuclear transport receptor
is then shuttled from the cytosol into the nucleus through
the nuclear pore complex by forming transient interactions
with nucleoporins that line the channel of the pore. In a pre-
vious search for NLS motifs in DNA repair proteins, no putative
NLS in S. cerevisiae Rad52 was identified and it was proposed
that Rad52 is escorted into the nucleus via an interaction
with another protein factor that harbors such a transport sig-
nal [17]. We have located the region in Rad52 required for
its nuclear localization. Combining these domain mapping
results with a complementary sequence analysis, we have
identified a single “pat7” type NLS in Rad52 and shown that
it is essential and sufficient for efficient Rad52 transport into
the nucleus. Interestingly, the functionality of this NLS seems
to be dependent on Rad52 oligomerization being mediated by
the N-terminus of the protein.
2. Materials and methods
2.1. Genetic methods and strains
All media were prepared as described by Sherman [18] with
minor modifications as the synthetic medium contained twice
the amount of leucine (60 mg/L). All strains are isogenic to
W303 [19] except they are RAD5 [20,21], and ADE2 (see Table 1).
Integrated RAD52 mutants were constructed and fused to YFP
using the cloning-free PCR-based allele replacement method
previously described by Erdeniz and colleagues [22,23]. Cor-
rect integration of the mutations were verified by PCR and
sequencing (MWG-Biotech AG).
2.2. Plasmid construction
2.2.1. Plasmids expressing MmRad52-YFP and
KlRad52-YFP
Plasmids were constructed from the CEN6-based plasmid
pWJ1213 [24] by replacing S. cerevisiae RAD52 with RAD52 from
Kluveromyces lactis and Mus musculus preserving the S. cere-
visiae RAD52 promoter. Both genes are lacking stop codons
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Table 1 – Yeast strains used in this study
Straina Genotype
UM74-3B MATa bar1::LEU2 his3-11, 15 leu2-3, 112
trp1-1 ura3-1 RAD52-YFP
UM94-9C MATa his3-11, 15 leu2-3,112 trp1-1 ura3-1
rad52-327-YFP
UM93-12D MATa his3-11, 15 leu2-3, 112 trp1-1 ura3-1
rad52-267-YFP
UM227-9D MATalpha his3-11, 15 leu2-3, 112 lys2 ura3-1
rad52-237-YFP
UM262-3B MATa his3-11, 15 leu2-3, 112 trp1 ura3-1
rad52-223-YFP
UM261-9C MATalpha his3-11, 15 leu2-3, 112 lys2 ura3-1
Rad52-207-YFP
UM69-1A MATa bar1::LEU2 can1-100 his3-11, 15 leu2-3,
112 trp1-1 ura3-1 rad52-207-CFP
UM94-5D MATa his3-11, 15 leu2-3,112 trp1-1 ura3-1
RAD52
UM263-7C MATalpha his3-11, 15 leu2-3, 112 lys2 ura3-1
RAD52-YFP
UMR128 MATalpha bar1::LEU2 his3-11, 15 trp1-1
ura3-1 rad52-R234A-YFP
W3849-10C MATa bar1::LEU2 his3-11, 15 ura3-1
RAD52-CFP
UM101-15B MATa his3-11, 15 leu2-3, 112 trp1-1 ura3-1
rad52::HIS5
a All strains are derivatives of W303-1A and W303-1B. In addition
to the genotype listed above all strains are RAD5 and ADE2.
to ensure fusion to YFP. The new vectors, pIPL2 and pIPL3,
harboring RAD52-YFP from either K. lactis or M. musculus were
transformed into a rad52 strain (UM101-15B) and nuclear
localization visualized by fluorescent microscopy.
2.2.2. Plasmids expressing Rad52-YFP
A series of plasmids expressing Rad52-YFP with mutations
in areas predicted to be involved in nuclear transport of
Rad52 were constructed. All plasmids were constructed by
inserting an AgeI-SphI digested RAD52 fragment into an
AgeI-SphI vector fragment of pWJ1213. Plasmids harboring
rad52-R148A-YFP and rad52-K150A-YFP were constructed from
two plasmids (p52mut-R148A and p52mut-K150A) previously
constructed by Mortensen et al. [25]. To create fragments
encoding the mutations rad52-KRR233-235AAA, rad52-R234A
and rad52-207-37, sequences flanking the mutation were
amplified by PCR. The primers used to construct the RAD52
plasmids are listed in supplementary material. The PCR frag-
ments were inserted into pWJ1213 with AgeI and SphI to
generate the plasmids pWJ1213-rad52-KRR233-235AAA-YFP,
pWJ1213-rad52-R234A-YFP and pWJ1213-rad52-207-37-YFP.
2.2.3. Plasmids expressing NLS-tagged Rad52-YFP
mutants
To tag rad52-207-237-YFP with the NLSSV40 sequence [26,27],
a PCR fragment encoding rad52-207-237-YFP-NLS was con-
structed by PCR using pWJ1213-rad52-207-237 as template.
The PCR fragment was inserted into vector pWJ1213 to gen-
erate pWJ1213-rad52-207-37-YFP-NLS using AgeI and XhoI. A
plasmid harboring rad52-R234A-YFP-NLS was constructed by
digestion of pWJ1213-rad52-207-37-YFP-NLS with SphI and
XhoI. The resulting fragment was inserted into a SphI-XhoI
vector fragment of pWJ1213-rad52-R234A-YFP to generate the
plasmid pWJ1213-rad52-R234A-YFP-NLS.
The CEN6-based RAD52-YFP expression vector, pWJ1213,
and the 2-micron-based RAD52-YFP vector pWJ1214 were used
to clone rad52MC-YFP and rad52C-YFP (primers are listed in
supplementary material).
2.2.4. Plasmids expressing mono- and tetrameric DsRed
tagged with the NLS of Rad52
Plasmids expressing either monomeric DsRed (pCupmono-
DsRed-NLSRad52) or tetrameric DsRed (Pcup-tetra-DsRed-
NLSRad52) tagged at the C-terminus with NLSRad52 (PNKRRQL)
were constructed from pCM1513 (A kind gift from C. Mu¨ller)
leading to a protein under the control of the inducible Cup1
promoter. A PCR fragment harboring monomeric DsRed-
NLSRad52 was constructed by PCR using pCM1513 as a template
(primers are listed in supplementary material), and a fragment
harboring tetrameric DsRed-NLSRad52 using pPgpdA-DsRed as
a template [28]. Both the monomeric and the tetrameric DsRed
containing PCR fragments were digested with HpaI-HindIII
and ligated into a HpaI-HindIII vector fragment of pCM1513.
Plasmids were transformed into UM94-5D and nuclear local-
ization was visualized by fluorescence microscopy.
2.3. MMS assay
To assess sensitivity of mutant strains to methyl methanesul-
fonate (MMS) (M4016 from Sigma), plasmids harboring wild
type RAD52, rad52-207-37-YFP, rad52-207-37-YFP-NLSSV40,
rad52-R234A-YFP, rad52-R234A-YFP-NLSSV40 and an empty
plasmid were transformed into a rad52 strain (UM101-15B).
Cells were grown overnight at 30 ◦C in selective media (SC-His),
washed with sterile water and resuspended in an appropriate
volume. Subsequently, six 10-fold dilutions were made of cell
suspensions containing 108 cells per ml and 5 l of each dilu-
tion was spotted on SC-His plates containing no or 0.0025%
MMS. Plates were incubated at 30 ◦C for 2 days before exami-
nation [29].
2.4. Fluorescence microscopy and imaging
Microscopy was essentially performed as previously described
[30]. Cells were grown in SC medium prior to microscopy,
except when RAD52 molecules were expressed from a plas-
mid. In this case, cells were grown in SC-His or SC-Leu medium
to select for the plasmid. When fluorescent molecules were
expressed under the control of the Cup1 promoter, CuSO4
was added to the inoculation media to a final concentration
of 0.2 mM Cu2+ to induce expression. In all experiments cells
were grown at 23 ◦C to allow efficient formation of the chro-
mophore.
DNA in living cells was stained for visualization by adding
10 g/ml DAPI to the culture 30 min prior to imaging. Selected
strains were made 0 (mitochondrial DNA negative) before
staining to eliminate any signal from mitochondrial DNA.
2.5. Co-expression of RAD52 strains
UM69-1A was crossed with UM261-9C, UM227-9D, and UM263-
7C to generate diploids rad52-207-CFP/rad52-207-YFP,
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rad52-207-CFP/rad52-237-YFP and rad52-207-CFP/RAD52-
YFP. Diploid cells were grown overnight in SC media and the
subcellular localization of the proteins examined by using flu-
orescence microscopy.
2.6. Purification of Rad52MC
(His)6-RAD52MC was constructed in pRSET-c and purified from
E. coli strain Rosetta (Novagen) as described (Krejci et. al., sub-
mitted).
2.7. Gel filtration analysis of Rad52MC
(His)6-tagged Rad52MC (100 g) was fractionated in a 36-ml
Sephacryl S300 column in K buffer containing 150 mM KCl,
collecting 0.4 ml fractions at 0.1 ml/min. The column fractions
were analyzed by 10% SDS-PAGE and staining with Coomassie
Blue. The column was calibrated with thyroglobulin (663 kDa),
catalase (223 kDa) and ovalbumin (43 kDa).
3. Results
3.1. Nuclear localization of Rad52 is mediated by a
region in the middle section of the protein
Rad52 of S. cerevisiae is predominantly localized in the nucleus
in all phases of the cell cycle, even in the absence of genotoxins
[23] and Fig. 2. To delimit the region in Rad52 required for its
nuclear localization, a series of five mutant strains expressing
YFP tagged C-terminally truncated Rad52 species expressed
from the endogenous RAD52 locus were constructed (Fig. 1).
These truncation alleles terminate at aa residue positions
ranging from 207 to 327, compared to wild-type Rad52, which
terminates at position 504. In addition, two N-terminally trun-
cated species, one starting from aa residue 169 (Rad52MC-YFP)
and one from aa residue 327 (Rad52C-YFP) were constructed.
All mutant strains were subjected to fluorescence microscopy
to determine the cellular localization of the fusion proteins.
Of these truncations, Rad52-327-YFP was expected to sort
into the nucleus because the MMS sensitivity of a rad52-327
strain has previously been shown to be fully suppressed by
over-expression of Rad51 [13,31]. In agreement with this, we
find that Rad52-327-YFP localizes in the nucleus. Interest-
ingly, we find that the truncation species Rad52-237-YFP
and Rad52-267-YFP also sort correctly into the nucleus
whereas the two shortest truncations, Rad52-207-YFP and
Rad52-223-YFP mainly localize in the cytosol (Figs. 1 and 2
supplementary material). In addition, the N-terminal trunca-
tions Rad52MC-YFP and Rad52C-YFP also fail to sort efficiently
to the nucleus. To rule out the possibility that mis-sorting
of the Rad52 truncation species could be explained by their
nuclear transport being compromised by the YFP moiety of the
fusion protein, we constructed a Rad52-YFP species contain-
ing an internal deletion, Rad52-207-237-YFP, and expressed
it from a single copy plasmid in a rad52 strain. This species
also fails to sort correctly to the nucleus (Fig. 1). Together these
results indicate that a region involved in nuclear localization
is located between or close to aa residues 207–237, a region of
the protein that has not previously been assigned any Rad52
function. However, the fact that Rad52MC-YFP, which contains
aa residues 207–237, accumulates in the cytosol (Figs. 1 and 2)
suggests that nuclear localization of Rad52 may also depend
on other Rad52 features, see below.
3.2. A nuclear localization signal is present in the
middle of Rad52
Next, we investigated the possibility that the domain respon-
sible for nuclear localization of Rad52 is sufficiently conserved
to retain interspecies functionality. Hence, K. lactis and M.
musculus Rad52 species (KlRad52 and MmRad52) tagged with
YFP were individually expressed under the control of the S.
cerevisiae RAD52 promoter from single copy plasmids in S.
cerevisiae rad52 strains. When these strains were examined
by fluorescence microscopy, we observed that KlRad52-YFP
locates in the nucleus whereas MmRad52-YFP mainly remains
in the cytosol (Fig. 3A) suggesting that a common mecha-
nism ensures nuclear localization of Rad52 and KlRad52, but
not MmRad52, in S. cerevisiae. In agreement with this view,
sequence comparisons of the aa residues 207–237 in Rad52
to the corresponding Rad52 sequences from K. lactis and M.
musculus show that only Rad52 and KlRad52 share identical
stretches of aa residues in this region (Fig. 3B). Importantly,
we find a proline residue at position 231 in Rad52 that is situ-
ated close to a stretch of three positively charged aa residues
(PNKRR). At the corresponding position, a similar motif is
present in KlRad52 (PSLKKR), but not in MmRad52. Both motifs
qualify as pat7 NLS sequences [32] and therefore constitute
sequences that may be involved in nuclear localization of
KlRad52 and Rad52 in S. cerevisiae. The fact that the putative
NLS sequence in Rad52 (and in KlRad52) only contains three
basic aa residues explains why it was not recognized in the
more stringent NLS search performed previously by Boulikas
[33,17] who defined a monopartite NLS motif as a cluster of
at least four basic residues within a hexapeptide. The exis-
tence of a pat7 type NLS in Rad52 prompted us to perform
a new sequence search for other putative NLS sequences in
the entire Rad52 primary sequence using two different algo-
rithms PSORT II and Predict NLS [32,34]. Using PSORT II, one
additional candidate sequence, a pat4 sequence (RRKP) [32]
at position 148–151 was identified. However, this motif is not
conserved in KlRad52 and MmRad52 (Fig. 3B).
3.3. A single NLS ensures nuclear localization of yeast
Rad52
Three basic aa residues (K233-R234-R235) constitute the core
of the predicted pat7 NLS identified in Rad52. To verify that
these aa residues in fact are part of an NLS, the triple
mutant Rad52-KRR233-235AAA-YFP and the single mutant
Rad52-R234A-YFP were individually expressed from single
copy plasmids in rad52 strains. In agreement with this motif
being an NLS, both Rad52-KRR233-235AAA-YFP and Rad52-
R234A-YFP were observed to remain mainly in the cytosol
(Figs. 1 and 2). To rule out the possibility that mis-sorting
was due to the Rad52 mutants being expressed from a plas-
mid, the R234A mutation was introduced into the genomic
version of RAD52-YFP. In the resulting strain, Rad52-R234A-
YFP was also observed to localize in the cytosol (unpublished
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Fig. 2 – Cellular localization of Rad52 mutant proteins. Microscopy of cells expressing Rad52-YFP or corresponding mutant
derivatives as indicated. Pictures shown are pseudocolored monochrome images. (For interpretation of the references to
color in this figure legend, the reader is referred to the web version of the article.)
data). Next, we investigated the role of the pat4 NLS motif
spanning aa residues 148–151 in nuclear sorting. Two mutant
Rad52 species, Rad52-R148A-YFP and Rad52-K150A-YFP, were
expressed from plasmids in rad52 strains and their cellular
location determined. Both mutants were found to be present
in the nucleus showing that this pat4 NLS motif plays lit-
tle or no role in the nuclear localization of Rad52 (Fig. 1). In
fact, this result was expected as two Rad52 mutant strains,
rad52-R148A and rad52-R149A, were previously shown to repair
-ray-induced damage and to perform mitotic homologous
recombination at wild-type levels [25] showing that sufficient
Rad52 protein must reach the nucleus to maintain these func-
tions. We therefore conclude that a single NLS of the pat7
type spanning aa residues 231–235 is responsible for targeting
Rad52 to the nucleus.
3.4. The NLSRad52 can direct a heterologous cytosolic
protein to the nucleus
To demonstrate that the PNKRR motif in Rad52 acts as a func-
tional NLS, we extended the C-terminus of monomeric DsRed,
which is normally located in the cytosol with an NLSRad52,
and asked whether the presence of this motif would direct
it to the nucleus. Surprisingly, this species fails to sort effi-
ciently to the nucleus (Fig. 4). In contrast, if monomeric DsRed
is C-terminally fused to the well-characterized NLS sequence
from SV40 virus, NLSSV40 [26,27], then monomeric DsRed local-
izes in the nucleus (data not shown). This result suggests
that a single NLSRad52 is insufficient to mediate the trans-
port of monomeric DsRed to the nucleus. Since some proteins
contain several NLS sequences to ensure efficient nuclear
sorting, we fused NLSRad52 to the C-terminus of tetrameric
DsRed to determine whether this protein complex that con-
tains a total of four NLSRad52 sequences would localize to
the nucleus. Unlike monomeric DsRed-NLSRad52 tetrameric
DsRed-NLSRad52 is highly concentrated in the nucleus (Fig. 4)
showing that the NLSRad52 can act as a functional NLS if it
is present in one copy in each of the subunits of a homo-
multimeric protein complex.
3.5. The role of Rad52 multimerization in nuclear
localization of Rad52
Rad52 exists as a heptameric ring-structure and the observa-
tion that the NLSRad52 promotes efficient nuclear localization
of tetrameric, but not monomeric, DsRed suggests that Rad52
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Fig. 3 – Localization of Rad52, KlRad52 and MmRad52 in S. cerevisiae cells. (A) rad52 cells expressing S. cerevisiae,
Kluveromyces lactis or Mus musculus Rad52-YFP fusion proteins from plasmids as indicated. Pictures shown are
pseudocolored monochrome images. (B) A sequence comparison of the region of Rad52, which is important for nuclear
targeting, to the corresponding regions of KlRad52 and MmRad52. Identical or similar aa residues are highlighted by yellow
and grey, respectively. The positions of the two predicted NLS sequences, pat4 and pat7, in S. cerevisiae Rad52 are indicated
as bold underscored aa residues. (For interpretation of the references to color in this figure legend, the reader is referred to
the web version of the article.)
multimerization may also be important for the nuclear local-
ization of Rad52. It would therefore be interesting to test
whether a Rad52 mutant that fails to form ring-structures,
yet contains the NLSRad52, sorts to the nucleus. In fact, the
fragment Rad52MC-YFP described above may represent such
a mutation as it lacks the N-terminal self-association domain
responsible for ring-structure formation, but contains the
NLSRad52 sequence. Importantly, this Rad52 fragment fails to
concentrate in the nucleus (Figs. 1 and 2). Since the C-terminus
of human Rad52 contains a self-association domain that
allows Rad52 ring structures to further multimerize [12], we
tested whether Rad52MC exists as a monomer or a multimer
as judged by a gel-filtration experiment. As shown in Fig. 5A,
Rad52MC elutes at a volume corresponding to that expected
if it forms a tetra- or pentamer. To investigate whether this C-
terminal self-association domain contributes to the nuclear
localization of Rad52, we co-expressed Rad52MC-YFP and
Rad52-CFP in the same strain. Of these two protein species,
only Rad52-CFP concentrates in the nucleus (Fig. 5B) indicat-
ing that the interaction between Rad52MC-YFP and Rad52-CFP
is not sufficiently strong to ensure Rad52-CFP mediated
nuclear localization of Rad52MC-YFP. Similarly, MC-NLSSV40
fails to mediate nuclear localization of Rad52-R234A-YFP
(data not shown). Finally, we asked whether the ability of
a sorting defective Rad52 mutant to participate in a multi-
meric ring-structure could promote its nuclear localization
if it is co-expressed with a sorting proficient Rad52 species.
This possibility was tested by co-expressing Rad52-207-CFP
with Rad52-237-YFP and by co-expressing Rad52-207-CFP
together with wild-type Rad52-YFP. In both cases, the NLS
defective Rad52 mutants were mainly located in the nucleus
(Fig. 5C) showing that Rad52 multimerization may facilitate
nuclear targeting.
3.6. The NLS region of Rad52 is not involved in the
DNA DSB repair functions of Rad52
Finally, we investigated whether the region of Rad52 con-
taining the NLS motif participates directly in DNA repair in
addition to its role in nuclear transport. To address this pos-
Fig. 4 – The pat7 NLS sequence in Rad52 is a functional NLS. The cellular localization of monomeric and tetrameric DsRed
tagged with NLSRad52. DsRed is depicted as a filled red circle and the NLSRad52 sequences as green flags. (For interpretation
of the references to color in this figure legend, the reader is referred to the web version of the article.)
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Fig. 5 – Rad52 self-association mediates nuclear transport. (A) Elution profile of Rad52MC after gel filtration. Fractions
eluting at the same volume as the marker proteins catalase and ovalbumin are indicated. (B) Expression of Rad52MC-YFP
from a plasmid in a RAD52-CFP strain. Co-localization of Rad52 species tagged with either CFP or YFP. (C) Microscopy of
heterozygous diploid strains co-expressing Rad52-207-CFP and Rad52-207-YFP, Rad52-207-CFP and Rad52-237-YFP
and Rad52-207-CFP and Rad52-YFP.
sibility, we tagged Rad52-R234A-YFP C-terminally with the
NLSSV40 to mediate its nuclear transport by a non-Rad52
sequence. As expected, this fusion protein is indeed con-
centrated in the nucleus (Fig. 2). The ability of the resulting
strain, rad52-R234A-YFP-NLSSV40, to perform Rad52 functions
during repair of MMS-induced damage was determined and
compared to that of rad52-R234A-YFP. As expected rad52-
R234A-YFP strains, like rad52 strains, are sensitive to MMS
reflecting the absence of Rad52 in the nucleus. In contrast,
rad52-R234A-YFP-NLSSV40 strains, like wild-type strains, were
not affected by this treatment (Fig. 6). In fact, it is possi-
ble to delete the entire region, aa residues 207–237, and still
maintain efficient DNA repair, as rad52 strains transformed
with a plasmid expressing Rad52-207-237-YFP-NLSSV40 are
resistant to MMS whereas rad52 strains expressing Rad52-
207-237-YFP are not (supplementary material). These results
show that the NLS region in Rad52 does not contribute directly
to repair of MMS-induced DNA damage.
4. Discussion
In the present study, we have explored the mechanism of
Rad52 nuclear localization by using a combination of muta-
genesis and sequence analysis. We have identified a single
pat7 type NLS, aa residues 231–235 (PNKRR), which is required
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Fig. 6 – A mutation in the pat7 NLS sequence in Rad52 does not affect its ability to repair MMS-induced DNA damage. A spot
assay of rad52 strains transformed with plasmids expressing RAD52-YFP rad52-R234A-YFP or rad52-R234A-YFP-NLSSV40 as
indicated. A strain transformed with an empty plasmid is also included in the analysis. Serial 10-fold dilutions of each
transformed strain were spotted on selective media containing either no or 0.0025% MMS. Pictures were captured after 2
days.
and sufficient for efficient nuclear localization of Rad52. This
NLSRad52 is a functional NLS sequence as tetrameric DsRed
tagged with NLSRad52 is sorted efficiently to the nucleus. In
some cases, an NLS sequence may provide a dual function in
a protein. For example, in many proteins the NLS sequences
overlap nucleic acid binding domains [35]. We observed, that
Rad52 mutants, where the NLSRad52 has been eliminated,
efficiently repair MMS-induced DNA damage when they are
tagged with NLSSV40. This suggests that the NLSRad52 only con-
tributes to nuclear sorting of Rad52.
The observation that the NLSRad52 only contains three
basic aa residues suggests that it may be a weak signal for
nuclear transport. In agreement with this, we find that a
single NLSRad52, in contrast to NLSSV40, does not mediate effi-
cient nuclear localization of monomeric DsRed. In addition,
the presence of four weak NLSRad52 sequences in tetrameric
DsRed-NLSRad52 efficiently mediates nuclear transport of this
protein complex. This result predicts that individual Rad52
subunits also do not accumulate in the nucleus. In agreement
with this view, we observed that the Rad52 N-terminal trunca-
tion, Rad52MC-YFP, fails to sort to the nucleus despite the fact
that it contains the NLSRad52 (Fig. 2). This Rad52 mutant pro-
tein does not contain the N-terminal protein oligomerization
domains responsible for ring-structure formation [7–9,15,36]
and the self-association of the MC part of Rad52 observed in
vitro ([12] and this study) does not seem to be sufficient for
nuclear localization in vivo. Taken together, we conclude that
Rad52 multimerization is an essential aspect of the nuclear
localization mechanism of Rad52 because the NLSRad52 is a
weak NLS.
Two models can explain how Rad52 multimerization drives
efficient nuclear localization (see Fig. 7). In the first model,
the additive NLS signal model (Fig. 7A), the heptameric ring is
formed in the cytosol, and the additive effect of seven weak
NLS sequences within a single Rad52 ring-structure drives
efficient nuclear targeting by, e.g. increasing the frequency
of interactions to the nuclear transport receptors. Rad52
monomers remain in the cytoplasm because each monomer
only contains a single weak NLS of Rad52, which is insufficient
to mediate any significant transport into the nucleus. In the
second model, the nuclear retention model (Fig. 7B), the hep-
tameric ring is formed in the nucleus. In this model, the weak
Rad52-NLS allows Rad52 to enter the nucleus at a slow rate as a
monomer. Moreover, in this model, Rad52 monomers exit the
nucleus at a similar rate preventing monomers from accumu-
lating in the nucleus. In contrast, Rad52 subunits, which are
incorporated into heptameric ring-structures, are trapped in
the nucleus, e.g. due to the larger size of this complex com-
pared to monomers. A similar model has been proposed to
explain nuclear localization of the pathogenic fusion protein
CBF-SMMHC (core binding factor beta fused to smooth mus-
cle myosin heavy chain) [37].
The effects predicted by the two models may both con-
tribute to the nuclear localization of Rad52. However, we note
that the nuclear retention model does not easily explain the
observation that Rad52-207-CFP and Rad52-237-YFP both
localize in the nucleus when they are co-expressed. For exam-
ple, in the nuclear retention model, Rad52-207-CFP enters
the nucleus independently of Rad52-237-YFP. Hence, Rad52-
207-CFP must be able to enter the nucleus independently
of the NLSRad52 sequence. This is unlikely as the size of
this fusion protein is approximately 47 kDa. Moreover, since
Rad52-207-CFP does not accumulate in the nucleus when
it is expressed on its own, the retention model predicts that
Rad52-207-CFP fails to multimerize in the nucleus since it
is not retained. This seems unlikely as the nuclear retention
model at the same time predicts that Rad52-207-CFP must be
efficiently incorporated into multimers together with Rad52-
237-YFP to ensure its nuclear retention in the co-expression
experiment. In contrast, in the additive NLS model, efficient
co-localization of Rad52-207-CFP and Rad52-237-YFP in the
nucleus is easily explained. In this model Rad52-207-CFP and
Rad52-237-YFP both form ring-structures in the cytosol, but
the Rad52-207-CFP ring-structures do not enter the nucleus,
as they do not contain any NLS sequences. However, when
the two species are co-expressed they form chimeric multi-
mers in the cytosol that enter the nucleus via NLS sequences
present in the Rad52-237-YFP molecules. In this context it is
important to note that the DsRed-NLSRad52 tetramer efficiently
sorts to the nucleus showing that four NLSRad52 sequences
are adequate for efficient nuclear transport. Since wild-type
Rad52 rings contain seven [36], and the Rad52 truncations may
even contain a higher number of subunits [12,38,39] then most
chimeric complexes should have enough NLSRad52 sequences
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Fig. 7 – The illustrations show two models explaining how
Rad52 multimerization may facilitate nuclear localization of
Rad52. Rad52 monomers are depicted as filled yellow
circles. The fact that each Rad52 molecule contains a single
NLS sequence is indicated by the presence of a single
“NLS” in each Rad52 monomer. The nuclear pore complex
is shown as blue cylinders. (A) The additive NLS model. (B)
The nuclear retention model. The models are explained in
detail in the text. (For interpretation of the references to
color in this figure legend, the reader is referred to the web
version of the article.)
to relocate efficiently to the nucleus. Finally, the nuclear reten-
tion model would likely depend on a mechanism preventing
Rad52 from multimerizing in the cytoplasm to ensure effi-
cient sorting. A similar level of complication is not required if
nuclear transport occurs according to the additive NLS model.
For these reasons, we favour a scenario where the mecha-
nism predicted by the additive NLS signal model provides the
driving force of Rad52 nuclear targeting.
The ability of Rad52 to form ring-like structures is evo-
lutionary conserved from yeast to humans [40,9,12], which
raises the question whether the nuclear sorting mechanism
is also conserved. A pat7 NLS sequence similar to the one in S.
cerevisiae, is present at the same position in Rad52 from K. lac-
tis, A. gossypii and C. glabrata suggesting that the mechanism
of nuclear transport of Rad52 is conserved in these yeasts.
In fact, we find that KlRad52 is sorted to the nucleus of S.
cerevisiae. This result was expected as it has previously been
demonstrated that expression of KlRad52 in S. cerevisiae par-
tially suppresses the severe phenotype of rad52 strains [13].
On the other hand, Rad52 homologs from higher eukaryotes,
e.g. chicken, zebra fish, mouse and human do not contain an
NLS at this position, but rather they have a single putative NLS
sequence in their C-terminal end suggesting that the Rad52
nuclear sorting mechanism may have diverged during evolu-
tion. Whether efficient nuclear targeting of Rad52 in higher
eukaryotes is dependent on Rad52 multimerization therefore
remains elusive. Lastly, S. cerevisiae contains a Rad52 homolog,
Rad59 [41]. Inspection of the Rad59 sequence by PSORT II and
Predict NLS did not reveal any NLS (data not shown). Inter-
estingly, it has previously been observed that Rad59 fails to
localize to the nucleus in the absence of Rad52 [42], and since
Rad52 and Rad59 interacts physically [10] it is likely that Rad52
and Rad59 are transported to the nucleus as a complex.
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5.1. Transport mutants of ScRad52 as scaffoldin candidates 
The work published in Plate et al., 2008a demonstrates that ScRad52 possesses several properties 
that makes it useful as a nano-platform scaffoldin.  Most importantly, ScRad52 forms ring-
structures that assemble in the cytosol of S. cerevisiae. Secondly, these ring-structures remain in 
the cytosol, if the nuclear localization signal (NLS) is removed and thirdly, ScRad52 seems to be 
mobile, as the protein can be redirected to the nucleus if it is tagged with the consensus NLS of 
SV40 virus. However, we also observe that when nuclear transport mutants are co-expressed 
with the wild type protein, both species sort to the nucleus. Accordingly, if a nuclear transport 
mutant of ScRad52 is used as a scaffoldin in a RAD52 strain, the platform will likely sort to the 
nucleus and not the cytoplasm. Therefore, experiments with a ScRad52 based nano-platform 
would have to be carried out in a rad52∆ strain in order to ensure cytosolic localization of the 
nano-platform. Unfortunately, a rad52∆ strain is likely to be a poor cell factory, as rad52∆ 
strains display growth defects and elevated mutation rates (Petes et al., 1991). As a consequence, 
I judged that nuclear transport mutants of ScRad52 are not suitable nano-platform scaffoldins. 
5.2. MmRad52 as a scaffoldin candidate for enzyme assembly in S. cerevisiae  
In the analysis of ScRad52’s transport mechanism, it was also investigated whether the 
mechanism of transport was conserved between species. Interestingly it was observed that the 
transport mechanism seems to be conserved between yeasts but not between yeast and higher 
eukaryotes, as Rad52 of Klyveromyces lactis sorted to the nucleus in a rad52∆ strain of S. 
cerevisiae whereas MmRad52 did not (Plate et al., 2008a). The fact that MmRad52 does not sort 
to the nucleus in S. cerevisiae, renders the possibility that MmRad52 could be applied as a 
scaffoldin in yeast. However, given that missorting species of ScRad52 are piggybacked to the 
nucleus by sorting species, MmRad52 could be piggybacked to the nucleus by ScRad52 in a 
similar way. To test this possibility, MmRad52-YFP was expressed in an S. cerevisiae strain 
expressing ScRad52-CFP from the genome. As a reference, the nuclear transport mutant 
ScRad52-R234A-YFP was also expressed in the same S. cerevisiae strain. Co-localization in the 
nucleus was observed for the nuclear transport mutant derived from ScRad52, but not for 
MmRad52, indicating that MmRad52 and ScRad52 do not interact in S. cerevisiae (Fig. 5-1). 
This prompted a further evaluation MmRad52’s ability to serve as scaffoldin for assembly of 
enzymes. 
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Figure 5.1. Co-expression of ScRad52 and either the nuclear transport mutant ScRad52-R234A-
YFP or MmRad52.  
 
Given the model described in Plate et al., 2008a, there could be two reasons for MmRad52 not 
sorting to the nucleus in S. cerevisiae. Either the NLS ensuring transport of MmRad52 in its 
native host is not recognized by S. cerevisiae or MmRad52 does not self-associate in S. 
cerevisiae. There is some evidence against both of these theories. An argument against the theory 
of a non-recognised NLS is that MmRad52 is predicted to contain an NLS consisting of 4 
positively charged amino acid residues in its C-terminal. Such an NLS may be categorized as a 
typical consensus NLS (Boulikas, 1996) and should therefore be functional in S. cerevisiae. An 
argument against the theory that MmRad52 does not self-associate in S. cerevisiae is that 
MmRad52 has been demonstrated to self-associate with the yeast two hybrid assay (Krejci et al., 
2000). The validity of this result can however questioned because the number of false positives 
identified by the yeast two hybrid assay has been estimated to be as high as 50% for 
heterologous proteins (Deane et al., 2002).    
 
DIC CFPYFP
MmRad52-YFP
ScRad52-CFP
+
ScRad52-CFP
+
ScRad52-R234A-YFP
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As none of the above options could clearly be ruled out and as the ability to self-associate is an 
essential property of the scaffoldin, it was of interest to demonstrate that MmRad52 self-
associates in S. cerevisiae. For this study a C-terminal truncation consisting of only the first 212 
amino acid residues of MmRad52 was used. The crystal structure has been solved for this exact 
truncation (Kagawa et al., 2002) and it appears that this N-terminal fragment of the protein is 
sufficient for ring-structure formation.   
 
To investigate whether MmRad52-∆212 self-associates in S. cerevisiae, it was exploited that 
molecules may be actively transported to the nucleus in two ways. They may contain an NLS 
within their own peptide sequence or they may interact with a molecule that contains an NLS 
(Boulikas, 1997). Based on this, an assay for determining whether MmRad52 self-associates in 
the cytosol of yeast was developed (Fig. 5-2). First, MmRad52 is tagged with either YFP or CFP 
and a consensus NLS. When these fusion proteins are expressed alone, the protein tagged with 
only YFP will reside in the cytosol, whereas the protein that has been tagged with CFP-NLS will 
sort to the nucleus. However, in the case of co-expression, the proteins localization will depend 
on whether they interact or not. If the proteins interact both proteins are expected to sort to the 
nucleus, whereas only the NLS-bearing molecule is expected to sort to the nucleus if no 
interaction occurs (Fig. 5-2).       
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Figure 5-2. Principle of nuclear transport assay. Both the YFP and the CFP bearing molecule will 
localize to the nucleus if MmRad52 self-associates, whereas only the CFP bearing molecule will 
localize to the nucleus if no self-association occurs.  
 
Initially, the localization of the separately expressed truncated species of MmRad52 was 
demonstrated to be as expected. When expressed alone MmRad52-∆212 tagged with YFP 
resided in the cytosol no matter whether the protein was tagged C- or N-terminally, whereas 
tagging of MmRad52-∆212  with the strong consensus NLS of SV40 virus and CFP ensured 
nuclear localization of this protein (data not shown).  
But when co-expressed, both the nuclear sorting molecule MmRad52-∆212-CFP-NLS and the 
otherwise cytosolic proteins MmRad52-∆212-YFP and YFP-MmRad52-∆212 localized to the 
nucleus (Fig. 5-3). The co-localization suggests that MmRad52-∆212 interacts in the cytosol of 
S. cerevisiae and forms heteromeric ring-structures containing both the CFP and the YFP tagged 
Nucleus
Cytosol
MmRad52-YFP MmRad52-CFP-NLS
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MmRad52 species. The fact that the co-localization was observed both when MmRad52-∆212 
was tagged C- and N-terminally with YFP indicates that neither N-terminal nor C-terminal 
tagging interferes with the ability to form ring-structures.     
 
Figure 5-3. Co-expression of the nuclear sorting molecule, MmRad52-CFP-NLS with the otherwise 
cytosolic proteins MmRad52-YFP and YFP-MmRad52.  Both the NLS bearing and the NLS 
lacking molecule co-localizes in the nucleus.   
 
In summary, an assay that possibly can be generally applied to determine protein interactions in 
vivo was developed. Using this nuclear transport assay, it was demonstrated that MmRad52-
∆212 self-associates in the cytoplasm of yeast. The result suggests that MmRad52 can be applied 
as a scaffoldin for assembly of at least two different enzymes, here exemplified by YFP and 
CFP. In the last chapter, it will be tested whether cell factories can benefit from enzyme 
assembly on an MmRad52-based nano-platform. 
 
  
DIC CFPYFP
CFP-MmRad52-∆212-NLS
+
MmRad52-∆212-YFP
CFP-MmRad52-∆212-NLS
+
YFP-MmRad52-∆212
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5.3. Materials and Methods 
 
5.3.1. Strains and plasmids 
 
The genotype and the source of the strains and plasmids used in this study are given in Table 5-1. 
To construct a plasmid expressing MmRad52-∆212-YFP, MmRad52-∆212 was PCR amplified 
with the primers M1 and M2, and YFP was PCR amplified with G1 and Y4. Subsequently, the 
two fragments were fused in a second round of PCR with M1 and Y4. Fragments encoding YFP-
MmRad52-∆212 and CFP-MmRad52-∆212-NLS were generated in a similar way except the 
primers were: G5, G6, M7 and M8 or C11, G6, M7 and M12. The fragments encoding 
MmRad52-∆212-YFP and YFP-MmRad52-∆212 were digested with ClaI and SacI and inserted 
into a ClaI-SacI vector fragment of pESC-his. The fragment encoding CFP-MmRad52-∆212-
NLS was inserted into an EagI-BglII vector fragment of pESC-ura.  
 
The sequence of all the primers used in this study is given in Table 5-2. 
 
Table 5-1. Strains and plasmids used in this study. 
Strains Genotype Source 
W3849-10C MATa bar1::LEU2 his3-11,15 ura3-1 RAD52-CFP U. Mortensen strain collection 
CEN.PK113-11C MATa MAL2-8c SUC2 ura3-52 his3∆1 Peter Köttera 
Plasmids Genotype Source 
pIPL3 CEN HIS3 PRAD52MmRad52-YFP Plate et al., 2008a  
pWJ1213-rad52-R234A CEN HIS3 PRAD52Rad52-R234A-YFP Plate et al., 2008a  
pESC-ura 2µ URA3 Stratagene  
pF1-2 2µ URA3 PGAL10MmRad52-∆212-YFP This study 
pF2-2 2µ URA3 PGAL10YFP-MmRad52-∆212 This study 
pESC-his 2µ HIS3 Stratagene 
pF4-8 2µ HIS3 PGAL10CFP-MmRad52-∆212-NLS This study 
aInstitut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany. 
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Table 5-2. Oligonucleotides used in this study.  
Primer name  Sequencea Template 
M1 gtatcgtagcatcgatATGGCTGGGCCTGAAGAAG MmRad52 
M2 cagtgaaaagttcttctcctttactcatcccATTCTGTCGGCAGCTGTTGT MmRad52 
M7 cacatggcatggatgaactatacaaagggATGGCTGGGCCTGAAGAAG MmRad52 
M8 ggagcatcggggagctcctaATTCTGTCGGCAGCTGTTGT MmRad52 
M12 ggagcatcgggagatctctactcgactttccgctttttcttcggagatgcATTCTGTCGGCAGCTGTTGT MmRad52 
G1 ATGAGTAAAGGAGAAGAACTTTTCACTG YFP/CFP 
Y4 ggagcatcggggagctcttaTTTGTATAGTTCATCCATGCCATGTGTAATCCC YFP/CFP 
G5 gtatcgtagcatcgatATGAGTAAAGGAGAAGAACTTTTCACTG YFP/CFP 
G6 TTTGTATAGTTCATCCATGCCATGTGTAATCCC YFP/CFP 
C11 gtatcgtagccggccgATGAGTAAAGGAGAAGAACTTTTCACTG YFP/CFP 
aThe parts of the nucleotide sequences shown in capitals are those that specifically anneal to the template DNA. The 
parts of the oligonucleotides that contain restriction sites and adaptamers are shown in lower-case.  
 
5.3.2. Co-expression of different Rad52 species in S. cerevisiae  
To investigate whether MmRad52 and ScRad52 interacts in S. cerevisiae, MmRad52-YFP was 
expressed in a strain expressing ScRad52-CFP. This was done by transforming and expressing 
the plasmid pIPL3 in the yeast strain (w3849-10C).   
To investigate whether MmRad52-∆212 self-associates in S. cerevisiae, an NLS tagged 
MmRad52 species was co-expressed with two different cytosolic species of MmRad52. This was 
done by transforming CEN.PK113-11C with pF4-8 and either pF1-2 or pF2-1. In this way strains 
expressing either CFP-MmRad52-∆212-NLS and MmRad52-∆212-YFP or CFP-MmRad52-
∆212-NLS and YFP-MmRad52-∆212 were constructed.  
 
5.3.3. Fluorescence microscopy 
Fluorescence microscopy was carried out as described in Albertsen et al., 2009. 
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Chapter 6: Effect of assembling metabolic enzymes on the nano-platform 
6.1. Introduction 
The cell may employ several different strategies for positioning sequentially acting enzymes in 
close proximity, as enzymes may sort to the same organelle, associate to form multifunctional 
complexes or dock on cellular structures such as the cytoskeleton or internal membranes. This 
spatial organization of enzymes has important implications for the efficiency, specificity and 
regulation of metabolic pathways (For reviews see Conrado et al., 2008, Ovadi and Srere, 2000, 
Winkel, 2004). Accordingly, it is of great interest to mimic nature’s way of organizing enzymes, 
in order to efficiently optimize novel metabolic pathways in cell factories. In Chapter 2 and 3, it 
was demonstrated that two novel pathways could be optimized by fusion of two sets of 
sequentially acting enzymes. As an alternative to enzyme fusion, catalytic sites can be brought in 
close proximity by assembling them on a scaffold. As early as the 1970’s, it was shown that 
reaction rates can be increased approximately two-fold by cross-linking consecutive enzymes to 
polymer-based scaffolds (Mosbach and Mattiasson, 1970, Srere et al., 1973). This technique can 
however not be easily applied in vivo. More recently a technique that seems easy to adapt for in 
vivo applications has been developed. This approach is inspired by nature’s way of organizing 
cellulases on their substrate cellulose. To ensure efficient targeting of cellulases to their 
substrate, simultaneously acting cellulases are assembled via docking domains on a scaffoldin 
that also contains a cellulose binding domain (See also section 1.4.1.3.). In this way all the 
enzymes required for cellulose breakdown are positioned in close proximity near their substrate. 
Inspired by this fascinating system for enzyme assembly, chimeric scaffoldins containing 
cohesin domains from different organisms has been generated (Fierobe et al., 2002, Fierobe 
et al., 2005). When these chimeric scaffoldins were mixed in vitro with cellulases containing 
different docking domains that specifically recognise a particular cohesin, it has been 
demonstrated that the cellulases can be incorporated at specific positions within the scaffoldin 
(Fierobe et al., 2005). Moreover, substrate breakdown could be accelerated when simultaneously 
acting cellulases from different species were assembled on the chimeric scaffoldin (Mingardon 
et al., 2007a). Inspired by these results, we decided to test whether scaffoldin mediated assembly 
of sequentially acting enzymes could be used to optimize two novel pathways in vivo. 
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In this study, it was chosen to use Rad52 as a scaffoldin for assembly of metabolic enzymes. 
This protein holds great potential for enzyme assembly because it is capable of forming a 
remarkably stable heptameric ring-structure (Ranatunga et al., 2001a, Stasiak et al., 2000). If 
metabolic enzymes are fused to such a multimeric protein, the multimeric protein’s ability to 
self-associate can be used to guide the assembly of several metabolic enzymes on a ring-shaped 
platform (See Fig. 4-1). In this study, a structure consisting of metabolic enzymes linked to a 
ring-shaped platform is termed a nano-platform. 
 
Rad52 is a well-characterized protein due to its important role in DNA repair. As a consequence, 
several of the proteins features have been investigated in detail. In the context of the nano-
platform, it is important to note that the domain responsible for ring-structure formation has been 
mapped to the N-terminal, more precisely amino acid residues 65-165 for HsRad52 (Shen et al., 
1996). Moreover, the crystal-structure has been solved for the C-terminal truncation of HsRad52 
(HsRad52-∆212) (Kagawa et al., 2002). The crystal structure revealed that this truncation of 
Rad52 forms a ring-structure with 11 subunits in the ring. As it is of interest to use a scaffoldin 
of minimal size for enzyme assembly, it was chosen to use a truncated version of Rad52 to form 
the core of the nano-platform. More specifically, MmRad52-∆212 rather than HsRad52 was 
chosen. Previously, we have worked with MmRad52 and shown that this protein is soluble and 
localizes to the cytosol when it is expressed in S. cerevisiae (Plate et al., 2008a). Moreover, as 
MmRad52-∆212 is 90% similar to HsRad52-∆212, MmRad52 is likely to form a structure 
similar to the one elucidated for HsRad52 and generally possess similar features.  
 
To investigate whether metabolic pathways could be optimized by enzyme assembly on a 
MmRad52-based nano-platform in the cytosol of S. cerevisiae, two model pathways were 
chosen. One that leads to sesquiterpene production and one that leads to vanillin glucoside 
production in yeast. In Chapter 2 and 3, it was demonstrated that these two pathways could 
benefit from having catalytic sites positioned in close proximity by enzyme fusion. Accordingly, 
they both provide excellent model pathways for testing whether pathways can benefit from 
scaffoldin mediated enzyme assembly. 
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To determine whether the sesquiterpene pathway can benefit from MmRad52 guided enzyme 
assembly, the effect of attaching FPPS and PTS to MmRad52-∆212 was examined by evaluating 
the functionality, the solubility and the patchoulol production from the nano-platform linked 
enzymes when they were expressed in S. cerevisiae. Next, it was investigated whether vanillin 
glucoside production could be optimized in yeast by positioning OMT and UGT on the nano-
platform. Here, the effect was evaluated by measuring growth rate, selected intermediate 
concentrations and the final concentrations of the end-product, vanillin glucoside. 
 
6.2. Materials and methods 
 
6.2.1. Strains and media 
The genotype of all the strains used in this study is given in Table 6-1. All media for genetic 
manipulations of yeast were prepared as described by (Sherman et al., 1986) with minor 
modifications as the synthetic medium contained twice the amount of leucine (60mg/L). A media 
allowing selection of hygromycin resistant colonies was prepared by adding hygromycin B to 
YPD to a final concentration of 300mg/L media.  
 
To construct erg20∆ strains expressing free FPPS, MmRad52-FPPS or FPPS-MmRad52, 
CEN.PK113-5D were transformed with the plasmids pLA001, pLA030 and pLA033. The 
resulting transformants were streak purified and retransformed with fragments designed to knock 
out ERG20. Fragments were prepared as described in Albertsen et al., 2009. 
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Table 6-1. Yeast strains used in this study. 
Strain Genotype Plasmid 
supplementation 
Source  
CEN.PK113-5D MATa MAL2-8c SUC2 ura3-52  Peter Köttera 
CEN.LA101 MATa erg20::hphMX MAL2-8c SUC2 ura3-52  pLA001 This study  
CEN.LA130 MATa erg20::hphMX MAL2-8c SUC2 ura3-52  pLA030 This study  
CEN.LA133 MATa erg20::hphMX MAL2-8c SUC2 ura3-52  pLA033 This study  
VAN265JH Mata, adh6::LEU2, bgl1::KanMX4, his3∆1, leu2∆0, 
met15∆, ura3∆0, PTPI1::3DSD- [AurC]::ACAR [HphMX] 
 This study         
(See section 3.2.1.) 
aInstitut für Mikrobiologie, der Johan Wolfgang Goethe-Universität, Frankfurt am Main, Germany. 
 
6.2.2. Plasmid construction 
The name and genotype of all plasmids used in this study are given in Table 6-2. The sequences 
of all oligonucleotides used for constructing plasmids are given in Table 6-3. 
FPPS and PTS constructs 
To fuse PTS to MmRad52-∆212, fragments encoding these enzymes were amplified separately 
using R3, R2, P1 and P4. Subsequently, the two fragments were fused in a second round of PCR. 
The resulting fusion PCR fragment was inserted into a BamHI-XhoI fragment of pESC-ura. 
FPPS and MmRad52-∆212 were fused to each other in the two possible configurations in a 
similar way and inserted into an EcoRI-ClaI vector fragment of the vector expressing 
MmRad52-∆212-PTS.    
To insert different linkers in between MmRad52-∆212 and PTS, fragments encoding PTS 
attached to the different linkers were obtained by digesting vectors expressing FPPS and PTS 
fused by different linkers with BspEI and XhoI (See Albertsen et al., 2009). The Linker-PTS 
fragments were inserted into a BspEI-XhoI vector fragment of pLA033. To insert the gene 
encoding CFP in between MmRad52-∆212 and PTS, a PCR fragment of CFP was amplified with 
G15 and G16 and inserted into a BspEI vector fragment of pLA033. To insert the gene encoding 
YFP in between the genes encoding MmRad52-∆212 and FPPS, a PCR fragment of YFP was 
inserted into a BssHII fragment of the pLA033 derived vector expressing MmRad52-∆212-FPPS 
and MmRad52-CFP-PTS.        
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OMT and UGT constructs 
To construct plasmids expressing OMT and UGT fused to MmRad52-∆212 in all possible 
combinations, OMT and UGT were fused to Mmrad52-∆212 using fusion PCR and the 
oligonucleotides given in Table 6-3. Generally, OMT encoding fragments were inserted into 
BamHI-XhoI vector fragments of pESC-his, whereas UGT encoding fragments were inserted into 
ClaI-PacI vector fragments of pESC-his derived vectors encoding OMT.  
 
The correct sequence of all cloned plasmids was verified by sequencing at MWG-biotech.  
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Table 6-2. Plasmids used in this study 
Name Genotypea Source 
pWJ669 MmRad52 Rodney Rothsteina  
pESC-ura 2µ URA3 Stratagene  
pIP029 2µ URA3 PGAL1-PatTps177 Asadollahi et al., 2008 
pLA001 2µ URA3 PGAL1PatTps177  PGAL10-ERG20 Albertsen et al., 2009 
pLA030 2µ URA3 PGAL10ERG20-MmRad52-∆212 PGAL1-MmRad52-∆212-SF-PatTps177 This study 
pLA031 2µ URA3 PGAL10-ERG20  PGAL1MmRad52-∆212- SF-PatTps177 This study 
pLA032 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1PatTps177 This study 
pLA033 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- SF-PatTps177 This study 
pLA034 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- LF-PatTps177 This study 
pLA035 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- SR-PatTps177 This study 
pLA036 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- LR-PatTps177 This study 
pLA037 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- S-PatTps177 This study 
pLA038 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆222-PatTps177 This study 
pLA039 2µ URA3 PGAL10MmRad52-∆212-ERG20  PGAL1-MmRad52-∆212- CFP-PatTps177 This study 
pLA040 2µ URA3 PGAL10MmRad52-∆212-YFP-ERG20 PGAL1-MmRad52-∆222-CFP-PatTps177 This study 
pLA041 URA3 PGAL10MmRad52-∆212-YFP-ERG20  PGAL1-MmRad52-∆222- CFP-PatTps177 This study 
pJH589 CEN URA3 EntD  Hansen et al., 2009 
pJH543 PTPI1hsOMT NatMX Hansen et al., 2009 
pJH665 CEN URA3 PTPI1UGT72E2 Hansen et al., 2009 
pESC-his 2µ HIS3 Stratagene 
pLA050 2µ HIS3 PGAL1MmRad52-∆212-hsOMT  PGAL10 MmRad52-∆212-UGT72E2 This study 
pLA051 2µ HIS3 PGAL1MmRad52-∆212-hsOMT  PGAL10 UGT72E2-MmRad52-∆212 This study 
pLA052 2µ HIS3 PGAL1hsOMT-MmRad52-∆212  PGAL10 MmRad52-∆212-UGT72E2 This study 
pLA053 2µ HIS3 PGAL1hsOMT-MmRad52-∆212  PGAL10 UGT72E2-MmRad52-∆212 This study 
a Department of Genetics and Development, Columbia University, USA. 
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Table 6-3. Oligonucleotides used in this study. 
Primer name  Sequencea Template 
E1 caacagctgccgacagaatggcgcgctaATGGCTTCAGAAAAAGAAAT ERG20 
E2 gtacgtagtgatcgatCTATTTGCTTCTCTTGTAAAC ERG20 
E4 gtatcgtagtcggccgATGGCTTCAGAAAAAGAAATTAGGAGAG ERG20 
E12 TTTACTTCTCTTGTAAACCTTGTTCAAAAACGC ERG20 
O1 agcatgacttaggatccATGGGTGACACTAAGGAGC OMT 
O2 caacagctgccgacagaatgggtccggaATGGGTGACACTAAGGAGC OMT 
O3 tctatcatggctcgagTTATGGACCAGCTTCAGAACC OMT 
O5 ggacttgtcacgtggtgccgggtccggaATGGGTGACACTAAGGAGC OMT 
P1 caacagctgccgacagaattccggaATGGAGTTGTATGCCCAAAG PatTps177 
P4 catgatgcgactcgagTTAATATGGAACAGGGTGAA PatTps177 
R1 gtatcgtagtgaattcATGGCTGGGCCTGAAGAAG MmRad52 
R2 ATTCTGTCGGCAGCTGTTGT MmRad52 
R3 ctgtagtcgtggatccATGGCTGGGCCTGAAGAAG MmRad52 
R4 gtatcgtagcatcgatATGGCTGGGCCTGAAGAAG MmRad52 
R5 gtatcgtagtcggccgATGGCTGGGCCTGAAGAAG MmRad52 
R11 caggttctgaagctggtccaggcgccggtATGGCTGGGCCTGAAGAAG MmRad52 
R12 ggacttgtcacgtggtgccgggtccggaATGGCTGGGCCTGAAGAAG MmRad52 
R13 tctagtaggcctcgagCTAATTCTGTCGGCAGCTGTTG MmRad52 
R14 agtactaggcttaattaaCTAATTCTGTCGGCAGCTGTTG MmRad52 
R17 cgtttttgaacaaggtttacaagagaagtaaaggcgcgctaATGGCTGGGCCTGAAGAAG MmRad52 
U2 caacagctgccgacagaatggagccggcATGCATATCACAAAACCACACG UGT 
U3 tgatagatccttaattaaCTAGGCACCACGTGACAAG UGT 
U4 ccagtagttgatcgatttcATGCATATCACAAAACCACACG UGT 
U6 GGCACCACGTGACAAGTCC UGT 
G15 gagcgactgtccggaATGAGTAAAGGAGAAGAACTTTTCACTG CFP 
G16 ctagtgcgtttccggaTTTGTATAGTTCATCCATGCCATGTG CFP 
aThe parts of the nucleotide sequences shown in capitals are those that specifically anneal to the template DNA. The 
parts of the oligonucleotides that contain restriction sites and adaptamers are shown in lower-case.  
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6.2.3. Shake flask experiments 
Shake flask experiments with the sesquiterpene producing strains were carried out as described 
in Albertsen et al. 2009, whereas shake flask experiments with vanillin glucoside producing 
strains were carried out as described in section 3.3.3. In all cases final titers of intermediates or 
end-products are averages of triplicates ± standard deviations.  
 
6.2.4. Fluorescent microscopy 
Microscopy was carried out as described in (Plate et al., 2008b).  
 
6.3. Results 
6.3.1. FPPS and PTS are functional in vivo when they are fused to the scaffoldin 
To benefit from MmRad52 guided enzyme assembly, the metabolic enzymes have to remain 
functional when fused to MmRad52. To test whether FPPS remains functional when it is fused to 
MmRad52-∆212 in the two possible configurations: MmRad52-∆212-FPPS and FPPS-
MmRad52-∆212, it was exploited that the gene encoding FPPS, ERG20, is essential for viability 
of S. cerevisiae. The functionality of FPPS can therefore be assessed by investigating whether 
these fusion proteins can sustain growth of a strain harbouring an ERG20 deletion. To this end, a 
haploid ERG20 strain was transformed with 4 different 2µ-based plasmids. One was an “empty” 
vector that served as a negative control, one was a plasmid that expresses FPPS as a free enzyme 
from PGAL10 and the last two were vectors expressed the fusion proteins MmRad52-∆212-FPPS 
and FPPS-MmRad52-∆212 from PGAL10.  The resulting transformants were streak purified and 
retransformed with gene targeting fragments specifically designed to knock out ERG20. In 
agreement with ERG20 being an essential gene, no transformants were obtained when the strain 
harbouring the empty plasmid was transformed with the ERG20 knock out fragments (data not 
shown). In contrast, transformants were obtained for the three strains harbouring plasmids 
expressing FPPS fused to MmRad52-∆212 in the two possible configurations or FPPS as a free 
enzyme. Hence, it is demonstrated that FPPS can sustain growth of a ∆erg20 strain both when it 
is linked to MmRad52-∆212 via its C- and N-terminal. It was however noted that the erg20∆ 
strains grew slower when they harboured the plasmids expressing MmRad52-∆212-FPPS or 
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FPPS-MmRad52-∆212 compared to when FPPS was expressed as a free enzyme suggesting that 
FPPS does not retain full activity when fused to the MmRad52-∆212 (Fig 6-1A). 
 
Next, it was tested whether PTS remains active after fusion to MmRad52-∆212. As patchoulol is 
not naturally produced by S. cerevisiae, patchoulol production was used as a measure to 
demonstrate that PTS is active. PTS can be fused to MmRad52-∆212 in two possible 
configurations, but only one of the possible configurations was tested here. Accordingly, a 
haploid ERG20 strain was transformed with and “empty” plasmid (negative control) or plasmids 
expressing MmRad52-∆212-PTS or PTS where the latter serves as a positive control. To assess 
whether the expression of MmRad52-∆212-PTS resulted in patchoulol production, the three 
strains described above were cultured in shake flasks according to the method described in 
materials and methods (See section 6.2.3.). Patchoulol production was observed both for the 
strain expressing MmRad52-∆212-PTS and for the one expressing PTS as a free enzyme. Thus, 
demonstrating that PTS is functional when fused to MmRad52-∆212 via its N-terminal (Fig. 6-
1B). As expected, no production of patchoulol was observed when the strain harboured an 
“empty” plasmid. Accordingly, PTS retains activity at least when fused to the scaffoldin via its 
N-terminal.       
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Figure 6-1. Functionality of FPPS and PTS when fused to MmRad52-∆212. A) Expression of FPPS 
(top), MmRad52-∆212-FPPS (left) and FPPS –MmRad52-∆212 (right) supports growth  
of a erg20∆ strain. B) Patchoulol is produced both when PTS is expressed as a free enzyme and 
when it is fused to MmRad52-∆212.  
 
6.3.2. Attachment of both enzymes to the nano-platform results in an increased patchoulol 
production compared to when only one enzyme is attached 
To investigate whether enzyme assembly of the two consecutive enzymes, FPPS and PTS on the 
MmRad52-based scaffoldin can increase the patchoulol production, ERG20 strains expressing 
PTS and FPPS as free enzymes or fused to MmRad52-∆212 were grown in shake flasks until 
they reached stationary phase. To determine how fusion to MmRad52-∆212 affects the activity 
of PTS and FPPS, strains expressing either FPPS or PTS fused to MmRad52-∆212 and the other 
enzyme as a free enzyme was also tested for patchoulol production (see Table 6-4). 
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Table 6-4. Patchoulol (PT) production from ERG20 strains expressing FPPS and PTS from 2µ-
based plasmids as individual enzymes or fused to MmRad52-∆212. 
Proteins expresseda 
 
Final PT titer 
[mg/L] 
Final PT yield 
[mg/L/OD600] 
 
5.1 ± 0.3 0.190 ± 0.022 
 
3.7 ± 0.4 0.122 ± 0.021 
 
0.7 ± 0.1 0.024 ± 0.004 
 
1.2 ± 0.1  0.044 ± 0.001 
a FPPS and PTS containing proteins were always expressed from PGAL10 and PGAL1, respectively. In all cases FPPS 
was also expressed endogenously. 
 
An 80% higher patchoulol production is observed when both FPPS and PTS are fused to 
MmRad52-∆212, compared to when only PTS is fused to MmRad52-∆212 (Table 6-4). The 
fusion of PTS to MmRad52-∆212 did however generally affect patchoulol production negatively, 
as a 7-fold lower patchoulol production was observed when PTS was fused to MmRad52-∆212 
compared to when it was expressed as a free enzyme. This suggests that PTS is not fully active 
when fused to MmRad52-∆212. The effect of fusing FPPS to MmRad52-∆212 is harder to assess 
because all experiments were carried out in an ERG20 strain which means that FPPS in all cases 
was also expressed endogenously as a free enzyme.   
 
6.3.3. Effect of linker type on the functionality of the scaffoldin linked PTS 
Since linker length and composition have been demonstrated to affect the specific activity 
(Carlsson et al., 1996), the catalytic efficiency (Lu and Feng, 2008), the stability (Prescott et al., 
1999) and the folding rates (Robinson and Sauer, 1998) of fusion proteins, it was next 
investigated whether the sesquiterpene synthase activity of the fusion protein, MmRad52-∆212-
PTS, could be increased by optimizing the linker between MmRad52-∆212 and PTS. In the 
experiment described in section 6.3.2., a short flexible linker consisting of Ser-Gly was used. To 
FPPS PTS+
FPPSRad52 PTS+
PTSRad52 FPPS+
+FPPSRad52 PTSRad52
Chapter 6: Effect of assembling metabolic enzymes on the nano-platform 
  92 
 
further evaluate the effect of linker length and composition, 6 additional linkers were tested. One 
linker was in fact a 10 amino acid residue extension of MmRad52-∆212 (Rad52-∆222).  The rest 
of the linkers were designed to be long flexible, short rigid, long rigid, stable or very long. The 
stable linker should be resistant towards degradation by proteases (Lu and Feng, 2008, Xue et al., 
2004) and the very long linker was in fact the sequence CFP. The amino acid residue sequences 
of the rest of the linkers are given in Table 6-5.    
 
Table 6-5: Effect of inserting linkers that varied in length and composition in between 
MmRad52-∆212 and PTS. The linker between MmRad52-∆212 and FPPS was in all cases a 
short linker (Gly-Ala-Leu).  
Proteins expresseda  Linker   
(composition) 
Effect of linkerb                                           
PT titerlinker / PT titershort flexible linker  
                                              
Short flexible        
(SG) 
1 
                                       
Long flexible 
(SGGGGS) 
0.99 ± 0.14 
                                 
      
    
                 
                                      
Short rigid 
(SGEAAAK) 
1.20 ± 0.03 
Long rigid 
(SGEAAAKEAAAK) 
1.36 ± 0.33 
Stable     
(SGMGSSSN) 
  0.61 ± 0.17* 
Extended scaffoldin 
(EALGLPKPQESG) 
0.69 ± 0.26 
Very long      
(Sequence of CFP) 
 0.37 ± 0.07* 
aAll subunits of the platform were expressed from 2µ-based plasmids. In all cases FPPS and PTS containing proteins 
were expressed from PGAL10 and PGAL1, respectively. 
bThe effect of a linker is given as patchoulol production using this linker relative to production achieved when the 
short flexible linker was used. 
*Patchoulol production using this linker is significantly different (p<0.05) from when the short flexible linker was 
used.  
 
+
FPPSRad52
PTSRad52
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No linkers capable of significantly increasing the patchoulol production beyond the short flexible 
linker were identified (Table 6-5). In contrast, two linkers that resulted in a significantly lower 
production of patchoulol compared to the short flexible linker were identified. These two linkers 
were the stable linker and the very long linker consisting of CFP. When the extended version of 
MmRad52-∆212 (MmRad52-∆222) was used as a scaffoldin no increases in production were 
achieved. Hence, truncating MmRad52 at another “random” position could not improve the 
performance of the scaffoldin linked PTS.    
 
6.3.5. The platform forms aggregates when expressed from a multi copy plasmid in S. 
cerevisiae 
To investigate whether the low production from the patchoulol producing nano-platform could 
be due to decreased expression levels, solubility or mislocalization of the nano-platform, the 
subcellular localization and the solubility of FPPS and PTS when they are fused to MmRad52-
∆212 was determined. To visualize the platform subunits, a plasmid expressing MmRad52-
∆212-YFP-FPPS and MmRad52-∆212-CFP-PTS was constructed (See Fig. 6-2A). The plasmid 
was constructed in two versions. One was a 2µ-based plasmid that allows proteins to be highly 
expressed and the other was an integrative plasmid that allows expression of a single copy of the 
construct from the genome. According to our previous observations, the expressed proteins are 
expected to self-assemble and form a nano-platform in the cytosol of yeast that displays CFP, 
YFP, FPPS and PTS activity (See Fig. 6-2B).   
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Figure 6-2. Fluorescent microscopy of the patchoulol producing nano-platform tagged with YFP 
and CFP. A) Construct used for fluorescent microscopy. B) Expected structure of the nano-plaform 
once it has assembled. C) Fluorescent microscopy of strains that expressed the fluorescently tagged 
nano-platform from either a 2µ-based plasmid or from a single copy on the genome. 
 
When the platform subunits were expressed from a 2µ-based plasmid, fluorescent aggregates 
displaying CFP and YFP activity were observed (Fig. 6-2C). The aggregates containing CFP and 
YFP often co-localize indicating that YFP and CFP containing subunits at least on some 
occasions are present in the same aggregate. To investigate whether the aggregate formation was 
related to over-expression, the nano-platform was also visualized when it was expressed from a 
single genomically integrated gene-cassette. When expression occurs from the genome, the 
expression level and the amounts of visible aggregates was severely reduced (Fig. 6-2C). 
 
It is also noted that the localization of the platform in all cases is cytosolic and that an even 
distribution of fluorescent signal is observed when expression occurs from the genome           
(Fig. 6-2C). In contrast the expression levels vary greatly among individual cells when 
DIC CFP YFP
Integrative plasmid
GAL1GAL10 PatTps177ERG20 TT YFP Rad52A  
2µ based plasmid 
Rad52 CFP
B
C
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expression occurs from the 2µ-based plasmid.   
 
6.3.6. Aggregate formation is not related to the patchoulol producing platform 
To investigate whether aggregate formation was related to the patchoulol producing nano-
platform, the tendency to form aggregates was tested for a nano-platform with no metabolic 
enzymes linked to it. To this end, MmRad52-∆212 was tagged with YFP and expressed from 
PGAL1 from a 2µ-based plasmid. To regulate the expression level, strains were grown in galactose 
media containing different amounts of glucose which is known to repress PGAL1.  
 
Figure 6-3. Expression of MmRad52-∆212-YFP from PGAL1, when strains were grown in media with 
decreasing glucose concentrations and increasing galactose concentrations.  
 
Aggregates were also observed when no enzymes except YFP were linked to the MmRad52-
∆212 (Fig. 6-3). The size of these aggregates increases with the expression level, and 
interestingly aggregates were also observed even when the expression level was relatively low. 
The same tendencies were observed when the expression of MmRad52-YFP was varied using 
the regulatable promoters CUP1 and MET25 (data not shown). It was also investigated whether 
aggregate formation is an effect of MmRad52-∆212 being a truncated protein. When we 
previously expressed full length MmRad52-YFP from the weak constitutive Rad52 promoter of 
S. cerevisiae, no aggregates were observed (Plate et al., 2008a). Accordingly, the observed 
aggregates could be due to the truncation. To rule out this possibility, MmRad52-∆212-YFP, 
BF
YFP
Galactose
Glucose 1.0%
1.0% 1.5%
0.5%
1.75%
0.25%
2.0%
0%
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MmRad52-∆222-YFP and MmRad52-YFP were all expressed from pGAL1 from a 2µ-based 
plasmid and subjected to fluorescence microscopy. Aggregates were observed for all three 
proteins and accordingly, the aggregation does not seem to be a consequence of the truncation 
(data not shown).     
 
6.3.7. Decreasing the expression level provides no additional benefits of enzyme assembly 
on the platform  
To investigate whether the low production of patchoulol from the assembled platform compared 
to the free enzymes is due to the nano-platform subunits tendency to form aggregates when it is 
highly expressed, the patchoulol production was determined when expression levels were 
decreased. In section 6.3.5., it was shown that expression levels can be substantially reduced by 
expressing the platform subunits from a single copy on the genome instead of from a 2µ-based 
plasmid. Accordingly integrative versions of the plasmids described in section 5.3.2. were 
constructed and the production of patchoulol was determined as previously described.  
 
Table 6-6. Patchoulol (PT) production from ERG20 strain expressing FPPS and PTS from the 
genome as individual enzymes or fused to the MmRad52-∆212. 
Proteins expresseda Final PT titer                            [mg/L] 
 
1.06 ± 0.07 
 
0.94 ± 0.13 
 
0.10 ± 0.01 
 
0.16 ± 0.02 
Cells were grown in 500ml shake flasks containing 100ml Delft media with 20g/L galactose. Final titers are 
averages of triplicates ± standard deviations. 
a FPPS and PTS containing proteins were always expressed from PGAL10 and PGAL1, respectively. In all cases FPPS 
was also expressed endogenously. 
 
FPPS PTS+
FPPSRad52 PTS+
PTSRad52 FPPS+
+FPPSRad52 PTSRad52
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When expression levels were decreased by expressing the nano-platform subunits from the 
genome, a 60% increase in patchoulol production is observed when both FPPS and PTS are 
linked to MmRad52-∆212, compared to when only PTS is MmRad52-∆212 linked (Table 6-6). It 
is also noted that the production from the scaffoldin linked enzymes is substantially lower than 
when the enzymes are expressed as free enzymes from the same promoters.  
 
6.3.8. Test of the nano-platform concept with the vanillin glucoside pathway as a model 
system  
The results above suggest that both FPPS and PTS are not fully functional when they are fused to 
MmRad52-∆212 (Fig. 6-1A, Table 6-4 and 6-6). To test whether the substantially reduced 
production from the patchoulol producing nano-platform compared to the free enzymes is due to 
PTS and FPPS being particularly sensitive to being fused to MmRad52-∆212, another model 
system was tested. To test a second model system, the enzymes catalyzing the last two steps in 
the pathway leading to vanillin glucoside, namely OMT and UGT were linked to MmRad52-
∆212. From the results presented in chapter 3, it is known that when these two enzymes are fused 
to each other, the configuration of the fusion enzymes can influence the functionality (see section 
3.3.1). Therefore OMT and UGT were fused to MmRad52-∆212 in all the possible 
configurations, to test whether the vanillin glucoside pathway could benefit from having OMT 
and UGT positioned on a nano-platform. The constructs were transformed in a strain producing 
the PAL, the substrate for OMT (See Chapter 3 for introduction to the vanillin pathway).   
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Table 6-7: Growth rate and final titers of vanillin glucoside (VG) and vanillin (VAN) when strains 
express OMT and UGT as individual enzymes or fused to the scaffoldin.  
Expressed proteins a 
 
Growth rate Final VG titer 
[mg/L] 
Final VAN titer 
[mg/L] 
 
0.108 ± 0.003 41.0 ± 2,5 3.7 ± 0.5 
 
0.127 ± 0.009* 21.5 ± 3.6* 0.9 ± 0.8* 
 
0.123 ± 0.003* 26.5 ± 2.4* 1.3 ± 0.1* 
 
0.117 ± 0.005 7.5 ± 0.2* 2.1 ± 0.1* 
 
0.111 ± 0.003 9.9 ± 0.7* 2.0 ± 0.1* 
a OMT and UGT containing proteins were always expressed from PGAL1 and PGAL10, respectively. 
*A significantly (p < 0.05) different growth rate or titer was observed for this strain compared to the strain 
expressing the free enzymes. 
 
Generally, the final titer of VG was lower when the strains expressed OMT and UGT fused to 
MmRad52-∆212 compared to when the enzymes were expressed as free enzymes from the same 
promoters. The VG production for the strains expressing OMT and UGT linked to MmRad52-
∆212 in the different configurations did however vary substantially and for the highest producing 
nano-platform the final titer of VG was only 35% lower than the production achieved with the 
free enzymes. It is also evident that OMT clearly prefers to be fused to MmRad52-∆212 via its 
N-terminal whereas UGT prefers to be fused via its C-terminal. 
Interestingly, a significantly (p<0.05) lower vanillin accumulation was observed for all the 
strains expressing the nano-platforms compared to the strains expressing the free enzymes. 
Moreover, a significantly higher growth rate was observed for the two nano-platforms that 
produced the highest amount of VG.  
+ UGTOMT
+OMTRad52 UGTRad52
+OMTRad52 Rad52UGT
+Rad52OMT UGTRad52
+Rad52OMT Rad52UGT
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6.4. Discussion 
At the first glance, there appears to be no advantages of attaching FPPS and PTS to the 
MmRad52 based nano-platform, as the patchoulol production was 4-6 fold lower when the 
enzymes were attached to the nano-platform compared to when they were expressed as free 
enzymes (Table 6-4 and Table 6-6). However, by attaching one enzyme at a time to the nano-
platform and express the other enzyme as a free enzyme, it is evident that PTS is affected 
negatively by being linked to MmRad52-∆212. Once this is taken into account when evaluating 
the effect of attaching enzymes to the nano-platform, a positive effect of linking FPPS and PTS 
to the MmRad52-based nano-platform is observed, as an up to 80%  increase in patchoulol 
production was found when both enzymes were attached to the nano-platform compared to when 
only PTS was. This provides the first proof that benefits may be achieved through positioning 
consecutive enzymes in close proximity on the self-assembling scaffoldin such as the one tested 
here.  
 
There could be at least two explanations for the decreased production from the nano-platform 
attached FPPS and PTS compared to their individual counterparts. First, the expression level 
could be lower when enzymes are fused to MmRad52-∆212 compared to when they are 
expressed as free enzymes. Visual assessment of the expression levels of fluorescently tagged 
enzymes that were either expressed as individual enzymes or fused to the MmRad52-∆212, 
indicates that differences in expression levels do not explain all of the observed difference as 
expression levels appear to be relatively similar (data not shown). Secondly, the enzymes may 
not retain full activity when they are fused to the scaffoldin. As already mentioned data suggest 
that PTS is less functional when it is fused to MmRad52-∆212. Furthermore, the activity of 
FPPS seems to be decreased as well, as erg20∆ strain expressing MmRad52-∆212-FPPS and 
FPPS-MmRad52-∆212 grew slower than the strain expressing FPPS as a free enzyme (Fig 6-1A 
and data not shown).  As it has been shown that the activity of FPPS can be decreased to about 
40% of wild type levels without affecting growth (Karst et al., 2004), the reduced growth of the 
erg20∆ strains observed when MmRad52-linked FPPS was highly expressed indicates that the 
activity of the scaffoldin linked enzyme is substantially decreased.  The negative effect of fusing 
FPPS to MmRad52 does however not appear to be due to a general tagging problem of FPPS, as 
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a two-fold higher patchoulol production was observed when FPPS was fused to PTS via its C-
terminal (Albertsen et al., 2009). Thus, indicating that in this case fusion does not impair the 
functionality of the enzyme. FPPS is however known to function as a dimer (Eberhardt and 
Rilling, 1975). When FPPS is linked to the nano-platform it is possibly more constrained in its 
movement than when it is fused to a monomeric protein such as PTS. Therefore, it is possible 
that fusion to a monomeric protein allows dimer formation and hence does not result in 
decreased activity whereas fusion to the nano-platform subunit does not allow dimer formation 
and this leads to a decreased activity of MmRad52 linked FPPS.     
 
Tagging of MmRad52 with fluorescent proteins revealed that the protein has a strong tendency to 
form large aggregates particularly when it is highly expressed. Aggregate formation is often 
observed when heterologous genes are over-expressed in E. coli (Garcia-Fruitos et al., 2005) and 
although aggregates are less common in yeast, they have also been observed (Binder et al., 1991, 
Hartig et al., 1990, Kamasawa et al., 1999). Aggregates have long been believed to consist of 
misfolded proteins that are formed because over-expression of proteins overloads the folding 
machinery (Gonzalez-Montalban et al., 2007). The theory is that if proteins are over-expressed a 
large amount of nascent protein chains will exit the ribosomes at the same time (Hartl and Hayer-
Hartl, 2002). Under these circumstances there are not sufficient amounts of chaperones to keep 
them separated till they are correctly folded and this results in aggregate formation because the 
nascent chains associate via hydrophobic interactions before they are completely folded. 
Recently, several studies have however observed that proteins in aggregates are biologically 
active (Ventura and Villaverde, 2006). In one case, the biological activity of the protein in 
aggregates was even increased compared to when the protein was not in aggregates (Garcia-
Fruitos et al., 2005). It is unknown whether the aggregates observed in this study affect the 
functionality of the proteins that are fused to MmRad52. The fact that they fluoresce indicates 
that the at least the fluorophore part of the molecule is correctly folded. Moreover, the benefits of 
attaching enzymes to the nano-platform were actually less pronounced when the platform was 
expressed in low levels where aggregates are expected to be substantially reduced compared to 
when they were highly expressed and expected to be in aggregates (Compare table 6-4 and 6-6). 
Furthermore, when the nano-platform concept was tested with another set of enzymes, namely 
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OMT and UGT, the production from the best producing nano-platform was only 35% lower than 
when the free enzymes were expressed indicating that most of the proteins in the aggregates are 
active. In summary, nothing indicates that the reduced activity of the nano-platform linked 
enzymes is due to the observed aggregates.  
 
But why are the aggregates formed? MmRad52 appears to be particularly aggregation prone, as 
aggregates are observed even when expression levels are low (see e.g. Fig. 6-3). The fact that 
MmRad52 possess the ability to self-associate renders the possibility that in the case of 
MmRad52 the aggregates are not to due to hydrophobic interactions between nascent chains but 
rather they are a result of Rad52’s ability to self-associate. It has been shown that the size of the 
Rad52 protein affects the number of subunits in the ring, as expression of the C-terminal 
truncation of HsRad52 results in the formation of ring-structures with 11 subunits in the ring 
(Kagawa et al., 2002, Singleton et al., 2002), whereas the expression the full length protein 
results in 7 subunits in the ring (Stasiak et al., 2000). Accordingly, extending the MmRad52 ORF 
with genes encoding other proteins, as it was done in this study, could affect the number of 
subunits in the ring. One possibility is that when the subunits become too big the ring is unable 
to close and this results in long polymer fragments that curl up on each other and form the 
observed aggregates.  
 
Generally enzyme fusion was shown to result in greater benefits than MmRad52 mediated 
enzyme assembly, as enzyme fusion was shown to be superior with respect to all the parameters 
measured in this study for both of the tested systems (Compare results presented in chapter 2 and 
3 with the result presented in this chapter). One of the advantages of assembling enzymes on the 
nano-platform compared to directly fusing them is the increased flexibility that the nano-
platform system provides. For example several enzymes may be attached to the nano-platform, 
enzyme ratios may be optimized and the metabolic enzymes may be fused via their preferred 
terminal (see also section 4.2). In this study the flexibility of the nano-platform system was not 
fully exploited as relatively simple model systems consisting of only two enzymes were tested. 
The fact that production from the nano-platform was within the same range when OMT and 
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UGT were attached to the nano-platform (Table 6-7) is a promising result. Both the studies 
where OMT and UGT were fused to each other and when they were fused to MmRad52-∆212 
revealed that these two enzymes preferred to be fused via a specific terminal. In the case of UGT 
the highest production was observed when it was fused via its C-terminal, whereas OMT 
preferred to be fused via its N-terminal. Accordingly, the proteins preferred tagging in different 
terminals and therefore a fusion protein where both proteins were tagged at their preferred 
terminal could be constructed. However, if the proteins had preferred to be fused via the same 
terminal, attachment to the nano-platform could possibly have been advantageous over the fusion 
strategy.  
 
Considering that a first proof of concept was demonstrated here with two relatively simple model 
systems where several parameters can be optimized, the nano-platform concept or a further 
development of the concept should have great potential for optimization of metabolic pathways 
in cell factories.  
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Chapter 7: Conclusion 
In order to develop new tools for optimization of cell factories, the effect of positioning 
sequentially acting enzymes in close proximity was studied in vivo. Two strategies for 
engineering catalytic sites to be in close proximity were tested. One strategy was to simply fuse 
the genes encoding the enzymes and in this way generate a bifunctional enzyme. The other 
strategy was to assemble metabolic enzymes on a nano-platform via fusion to a self-associating 
protein. Both strategies were tested with two model systems that each consisted of two 
sequentially acting enzymes. The model systems were chosen because they for different reasons 
were particularly likely to benefit from enzyme proximity. The first model system consisted of 
the enzymes catalysing the last two steps in the pathway leading to patchoulol synthesis in yeast, 
namely FPPS and PTS. In this pathway, flux towards sesquiterpenes is believed to be limited 
because there is competition for the intermediate FPP and because FPP mediates negative 
feedback on a preceding pathway step. The second model system consisted of OMT and UGT -
the enzymes that catalyse the last two steps in a novel pathway leading to VG synthesis in S. 
cerevisiae. The efficiency of this pathway is believed to be compromised for at least three 
reasons. First, accumulation of the toxic intermediate vanillin inhibits cell growth. Secondly, 
competition for enzyme leads to less efficient glycosylation of the target intermediate. Thirdly, 
the intermediate is lost through degradation and diffusion.    
 
In the first part of the project, the effect of fusing either FPPS and PTS or OMT and UGT was 
examined (Chapter 2 and 3). The effect of fusion on final titers, intermediate pools and growth 
rates were investigated. When FPPS and PTS were fused, enzyme fusion resulted in a two-fold 
higher patchoulol production compared to the separate counterparts. Moreover, the strategy 
could be used in combination with a traditional metabolic engineering strategy, as ERG9 
repression and enzyme fusion combined could increase patchoulol production almost five-fold. 
When OMT and UGT were fused, enzyme fusion could efficiently decrease the accumulation of 
the toxic intermediate vanillin and presumably this resulted in a higher growth rate and an 
increased production rate. The benefits that could be achieved by enzyme fusion were shown to 
depend largely on the orientation of the enzymes within the fusion protein and to a certain degree 
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on the linkers that were used to combine the individual proteins. In summary the first part of the 
project demonstrated that both of these systems could be optimized by enzyme proximity and 
accordingly these two pathways were suitable model systems for testing the second strategy for 
positioning catalytic sites in close proximity. 
  
In the second part of the project, a new tool for positioning enzymes in close proximity was 
developed and tested (Chapter 4-6). The developed tool involves the assembly of metabolic 
enzymes on a protein-based scaffold in vivo – here termed a nano-platform. The assembly occurs 
post-translationally and is guided by a self-associating protein. In Chapter 5, MmRad52-∆212 
was identified as a suitable scaffoldin for forming the nano-platform core, as it was demonstrated 
to self-associate in the cytosol of yeast when it was tagged with two model enzymes. In Chapter 
6, the effect of attaching metabolic enzymes to the MmRad52-based scaffoldin was investigated 
using the two model systems described above.  For both the sesquiterpene and the vanillin 
system, proximity effects were observed when the enzymes were attached to the nano-platform, 
but in both cases the system was not competitive with expression of the free enzymes with 
respect to final titers of end-product. Presumably, the lower production is at least partly due to 
decreased functionality of the enzymes when they are linked to the scaffoldin. 
 
7.1. Future perspectives 
In a further development of the nano-platform concept, enzymes could be attached to the nano-
platform via compatible cohesin and docking domains instead of being directly fused to the 
nano-platform subunits. In this case a universal nano-platform core displaying different types of 
cohesins could be constructed.  The attachment of enzymes to such a nano-platform would only 
require that the metabolic enzymes are fused to a docking sequence that is specifically 
recognised by one of the cohesins displayed on the nano-platform. One of the advantages of this 
system over the approach used in this study would be that it would require less work to attach 
enzymes to the nano-platform. Possibly, fusion to a docking sequence will also affect protein 
folding and expression less than attachment to a whole protein.  
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The field engaged in engineering of the spatial organization of pathways is an emerging research 
field that is likely to benefit from advances within the field of protein structure prediction. In this 
project no attempts were made to predict the distance between catalytic sites when enzymes were 
engineered to be in close proximity by either enzyme fusion or nano-platform mediated 
assembly. Here, all engineering attempts were carried out on a trial and error basis. The 
experiments clearly showed that the efficiency of the strategies is dependent on the orientation of 
the enzymes and the linker sequences used to connect the fusion proteins. By predicting the 
structure of chimeric proteins as the ones generated in this project, it may be possible to envision 
how enzymes should be fused to each other or to the nano-platform in order to minimise the 
distance between catalytic sites. In this way, chimeric structures that allow pathways to benefit 
utmost from proximity effects may be generated using a more rational approach.  
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